Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Polymorphism, Single Nucleotide | 290 | 2021 | 2357 | 15.200 |
Why?
|
Genetic Predisposition to Disease | 176 | 2021 | 2271 | 8.990 |
Why?
|
Genome-Wide Association Study | 152 | 2022 | 1621 | 7.390 |
Why?
|
Gene Expression Regulation, Neoplastic | 114 | 2020 | 1197 | 6.670 |
Why?
|
Lung Neoplasms | 76 | 2020 | 2262 | 6.030 |
Why?
|
Cancer Vaccines | 32 | 2022 | 156 | 5.960 |
Why?
|
Histone-Lysine N-Methyltransferase | 29 | 2023 | 154 | 5.340 |
Why?
|
Gene Expression Profiling | 95 | 2018 | 1384 | 5.260 |
Why?
|
Oligonucleotide Array Sequence Analysis | 105 | 2016 | 689 | 5.160 |
Why?
|
Breast Neoplasms | 70 | 2022 | 2903 | 5.090 |
Why?
|
Neoplasms | 61 | 2023 | 2898 | 4.840 |
Why?
|
Humans | 802 | 2024 | 86643 | 4.790 |
Why?
|
Japan | 130 | 2021 | 307 | 4.750 |
Why?
|
Cell Line, Tumor | 163 | 2021 | 2426 | 4.630 |
Why?
|
Immunotherapy | 24 | 2021 | 629 | 4.230 |
Why?
|
Antigens, Neoplasm | 28 | 2023 | 325 | 3.910 |
Why?
|
Nuclear Proteins | 35 | 2017 | 696 | 3.750 |
Why?
|
Biomarkers, Tumor | 62 | 2022 | 1464 | 3.750 |
Why?
|
Pharmacogenetics | 24 | 2024 | 434 | 3.530 |
Why?
|
Cell Proliferation | 64 | 2020 | 1578 | 3.500 |
Why?
|
Case-Control Studies | 138 | 2021 | 1805 | 3.490 |
Why?
|
Genotype | 120 | 2021 | 1851 | 3.350 |
Why?
|
Genome, Human | 48 | 2014 | 756 | 3.300 |
Why?
|
Female | 377 | 2022 | 44532 | 3.220 |
Why?
|
Tumor Suppressor Protein p53 | 28 | 2020 | 381 | 3.190 |
Why?
|
Cytochrome P-450 CYP2D6 | 17 | 2016 | 52 | 3.150 |
Why?
|
Neoplasm Proteins | 30 | 2018 | 532 | 3.140 |
Why?
|
Stomach Neoplasms | 21 | 2020 | 266 | 3.050 |
Why?
|
Precision Medicine | 12 | 2021 | 395 | 3.030 |
Why?
|
Middle Aged | 274 | 2022 | 25028 | 3.020 |
Why?
|
Receptors, Antigen, T-Cell | 16 | 2022 | 372 | 3.000 |
Why?
|
Cell Cycle Proteins | 26 | 2017 | 388 | 2.990 |
Why?
|
Aged | 226 | 2022 | 18415 | 2.970 |
Why?
|
Antineoplastic Agents | 44 | 2021 | 2360 | 2.950 |
Why?
|
Tamoxifen | 18 | 2019 | 168 | 2.940 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 84 | 2013 | 879 | 2.930 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 9 | 2022 | 123 | 2.890 |
Why?
|
Genetic Loci | 35 | 2021 | 250 | 2.790 |
Why?
|
Male | 328 | 2024 | 40965 | 2.730 |
Why?
|
Linkage Disequilibrium | 76 | 2019 | 473 | 2.710 |
Why?
|
Transcription Factors | 40 | 2020 | 1565 | 2.680 |
Why?
|
Peptides | 25 | 2023 | 639 | 2.680 |
Why?
|
Protein Kinase Inhibitors | 14 | 2019 | 589 | 2.660 |
Why?
|
DNA-Binding Proteins | 41 | 2018 | 1208 | 2.630 |
Why?
|
Genetic Variation | 51 | 2020 | 1351 | 2.620 |
Why?
|
Esophageal Neoplasms | 19 | 2022 | 321 | 2.600 |
Why?
|
RNA, Small Interfering | 71 | 2019 | 547 | 2.550 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 33 | 2018 | 1075 | 2.550 |
Why?
|
Urinary Bladder Neoplasms | 18 | 2018 | 383 | 2.400 |
Why?
|
Carrier Proteins | 26 | 2016 | 673 | 2.380 |
Why?
|
Up-Regulation | 43 | 2020 | 712 | 2.380 |
Why?
|
Gene Frequency | 70 | 2020 | 677 | 2.290 |
Why?
|
N-Acetylgalactosaminyltransferases | 7 | 2019 | 12 | 2.290 |
Why?
|
Colorectal Neoplasms | 34 | 2021 | 938 | 2.290 |
Why?
|
Pancreatic Neoplasms | 25 | 2022 | 645 | 2.280 |
Why?
|
Polymorphism, Genetic | 32 | 2017 | 819 | 2.240 |
Why?
|
Adult | 199 | 2022 | 25648 | 2.200 |
Why?
|
Alleles | 59 | 2018 | 1128 | 2.160 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 9 | 2019 | 101 | 2.150 |
Why?
|
Head and Neck Neoplasms | 11 | 2023 | 1052 | 2.100 |
Why?
|
Haplotypes | 53 | 2013 | 642 | 2.070 |
Why?
|
Membrane Proteins | 19 | 2016 | 1196 | 2.060 |
Why?
|
Neoplastic Stem Cells | 6 | 2020 | 143 | 2.060 |
Why?
|
Tumor Microenvironment | 9 | 2022 | 418 | 2.020 |
Why?
|
Mutation | 40 | 2022 | 3968 | 2.000 |
Why?
|
Aged, 80 and over | 87 | 2020 | 6509 | 1.950 |
Why?
|
Antineoplastic Agents, Hormonal | 13 | 2019 | 150 | 1.950 |
Why?
|
Cell Transformation, Neoplastic | 19 | 2017 | 427 | 1.930 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 17 | 2019 | 2438 | 1.920 |
Why?
|
Repressor Proteins | 17 | 2020 | 403 | 1.920 |
Why?
|
Carcinoma, Renal Cell | 13 | 2016 | 426 | 1.900 |
Why?
|
CD8-Positive T-Lymphocytes | 10 | 2023 | 559 | 1.890 |
Why?
|
Histones | 17 | 2020 | 311 | 1.880 |
Why?
|
Carcinoma, Squamous Cell | 21 | 2017 | 1076 | 1.870 |
Why?
|
DNA, Complementary | 34 | 2012 | 393 | 1.860 |
Why?
|
GTPase-Activating Proteins | 7 | 2020 | 65 | 1.860 |
Why?
|
Adenocarcinoma | 27 | 2018 | 1169 | 1.830 |
Why?
|
Molecular Sequence Data | 68 | 2015 | 3030 | 1.820 |
Why?
|
T-Lymphocytes, Cytotoxic | 28 | 2022 | 315 | 1.780 |
Why?
|
Kidney Neoplasms | 14 | 2016 | 621 | 1.770 |
Why?
|
Lysine | 13 | 2020 | 147 | 1.770 |
Why?
|
Biological Specimen Banks | 18 | 2021 | 65 | 1.760 |
Why?
|
Apoptosis | 42 | 2020 | 1683 | 1.700 |
Why?
|
Methylation | 25 | 2018 | 251 | 1.690 |
Why?
|
Signal Transduction | 41 | 2018 | 3241 | 1.690 |
Why?
|
Circulating Tumor DNA | 6 | 2022 | 37 | 1.680 |
Why?
|
Genomics | 8 | 2021 | 720 | 1.680 |
Why?
|
Sequence Analysis, DNA | 27 | 2020 | 853 | 1.670 |
Why?
|
Intracellular Signaling Peptides and Proteins | 18 | 2016 | 379 | 1.650 |
Why?
|
Chromosome Mapping | 37 | 2019 | 1074 | 1.600 |
Why?
|
Carcinoma, Hepatocellular | 19 | 2018 | 384 | 1.580 |
Why?
|
Proteins | 19 | 2013 | 777 | 1.580 |
Why?
|
Liver Neoplasms | 23 | 2018 | 736 | 1.570 |
Why?
|
Proto-Oncogene Proteins c-akt | 12 | 2016 | 322 | 1.560 |
Why?
|
Naphthyridines | 6 | 2019 | 53 | 1.560 |
Why?
|
DNA | 19 | 2013 | 1294 | 1.540 |
Why?
|
Prognosis | 62 | 2020 | 3679 | 1.540 |
Why?
|
Dendritic Cells | 9 | 2023 | 425 | 1.520 |
Why?
|
Epitopes, T-Lymphocyte | 9 | 2022 | 89 | 1.510 |
Why?
|
T-Lymphocytes | 12 | 2021 | 1195 | 1.490 |
Why?
|
Ovarian Neoplasms | 8 | 2020 | 744 | 1.480 |
Why?
|
Receptors, Cell Surface | 8 | 2014 | 286 | 1.470 |
Why?
|
Ubiquitin-Protein Ligases | 17 | 2023 | 165 | 1.460 |
Why?
|
Hepatitis C, Chronic | 17 | 2013 | 126 | 1.460 |
Why?
|
Transfection | 44 | 2016 | 896 | 1.440 |
Why?
|
Lymph Nodes | 7 | 2022 | 533 | 1.430 |
Why?
|
Animals | 149 | 2023 | 26582 | 1.420 |
Why?
|
High-Throughput Nucleotide Sequencing | 13 | 2022 | 456 | 1.410 |
Why?
|
Mice | 104 | 2023 | 11352 | 1.410 |
Why?
|
Protein Processing, Post-Translational | 12 | 2018 | 371 | 1.400 |
Why?
|
Leukemia, Myeloid, Acute | 6 | 2015 | 763 | 1.390 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 4 | 2018 | 100 | 1.390 |
Why?
|
Tumor Cells, Cultured | 38 | 2020 | 1041 | 1.370 |
Why?
|
Vaccines, Subunit | 13 | 2018 | 55 | 1.350 |
Why?
|
Interleukins | 15 | 2013 | 134 | 1.350 |
Why?
|
Sarcoma, Synovial | 9 | 2021 | 21 | 1.330 |
Why?
|
Protein-Tyrosine Kinases | 8 | 2015 | 302 | 1.330 |
Why?
|
Molecular Targeted Therapy | 8 | 2017 | 266 | 1.330 |
Why?
|
Diabetes Mellitus, Type 2 | 19 | 2017 | 1373 | 1.330 |
Why?
|
Arthritis, Rheumatoid | 18 | 2013 | 166 | 1.320 |
Why?
|
Base Sequence | 52 | 2020 | 2330 | 1.320 |
Why?
|
Epitopes | 17 | 2023 | 255 | 1.300 |
Why?
|
Gene Knockdown Techniques | 16 | 2019 | 236 | 1.290 |
Why?
|
Colonic Neoplasms | 16 | 2017 | 556 | 1.290 |
Why?
|
Trans-Activators | 15 | 2014 | 429 | 1.290 |
Why?
|
ErbB Receptors | 8 | 2019 | 485 | 1.270 |
Why?
|
Carcinoma, Pancreatic Ductal | 9 | 2011 | 108 | 1.270 |
Why?
|
Amino Acid Sequence | 42 | 2016 | 2062 | 1.260 |
Why?
|
Receptors, G-Protein-Coupled | 12 | 2009 | 115 | 1.250 |
Why?
|
Prostatic Neoplasms | 21 | 2024 | 1721 | 1.240 |
Why?
|
COS Cells | 35 | 2016 | 166 | 1.230 |
Why?
|
Transcription, Genetic | 25 | 2017 | 1135 | 1.210 |
Why?
|
Uterine Cervical Neoplasms | 6 | 2020 | 275 | 1.180 |
Why?
|
Tumor Suppressor Proteins | 17 | 2012 | 279 | 1.160 |
Why?
|
Immunohistochemistry | 49 | 2020 | 1753 | 1.150 |
Why?
|
Warfarin | 5 | 2013 | 103 | 1.130 |
Why?
|
Promoter Regions, Genetic | 37 | 2019 | 937 | 1.120 |
Why?
|
HLA-A Antigens | 11 | 2022 | 44 | 1.120 |
Why?
|
Blotting, Western | 29 | 2015 | 782 | 1.110 |
Why?
|
Immunoglobulin Isotypes | 2 | 2018 | 32 | 1.090 |
Why?
|
Asthma | 19 | 2016 | 955 | 1.090 |
Why?
|
Genetic Association Studies | 13 | 2021 | 294 | 1.090 |
Why?
|
Phosphorylation | 27 | 2017 | 1106 | 1.080 |
Why?
|
RNA, Messenger | 50 | 2018 | 1981 | 1.080 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 6 | 2018 | 27 | 1.070 |
Why?
|
Chromosomal Proteins, Non-Histone | 5 | 2015 | 58 | 1.070 |
Why?
|
Intracranial Aneurysm | 5 | 2016 | 158 | 1.050 |
Why?
|
ATP-Binding Cassette Transporters | 8 | 2010 | 141 | 1.050 |
Why?
|
Antiviral Agents | 17 | 2012 | 510 | 1.040 |
Why?
|
Exome | 2 | 2016 | 127 | 1.040 |
Why?
|
Drug Resistance, Neoplasm | 11 | 2020 | 592 | 1.030 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 6 | 2013 | 44 | 1.020 |
Why?
|
Polymerase Chain Reaction | 22 | 2011 | 927 | 1.020 |
Why?
|
Leukopenia | 5 | 2016 | 65 | 1.020 |
Why?
|
Blotting, Northern | 25 | 2012 | 256 | 1.020 |
Why?
|
Neoplasms, Hormone-Dependent | 5 | 2012 | 40 | 1.010 |
Why?
|
Histocompatibility Antigens Class I | 6 | 2020 | 203 | 1.010 |
Why?
|
Immunotherapy, Active | 2 | 2022 | 15 | 1.010 |
Why?
|
Interferon-alpha | 11 | 2012 | 233 | 1.000 |
Why?
|
Treatment Outcome | 43 | 2021 | 7993 | 0.990 |
Why?
|
Chromosomes, Human, Pair 1 | 13 | 2014 | 100 | 0.990 |
Why?
|
Glomerulonephritis, IGA | 5 | 2006 | 10 | 0.990 |
Why?
|
RNA Interference | 25 | 2017 | 369 | 0.990 |
Why?
|
Protein Binding | 32 | 2017 | 1456 | 0.980 |
Why?
|
DNA Methylation | 11 | 2020 | 628 | 0.980 |
Why?
|
Small Cell Lung Carcinoma | 3 | 2017 | 98 | 0.980 |
Why?
|
Cord Blood Stem Cell Transplantation | 2 | 2015 | 93 | 0.980 |
Why?
|
Anti-HIV Agents | 3 | 2011 | 149 | 0.970 |
Why?
|
Chromosomes, Human, Pair 6 | 9 | 2012 | 125 | 0.970 |
Why?
|
Protein Methyltransferases | 5 | 2018 | 14 | 0.970 |
Why?
|
Early Detection of Cancer | 2 | 2019 | 394 | 0.970 |
Why?
|
Down-Regulation | 22 | 2019 | 504 | 0.950 |
Why?
|
Gene Expression Regulation | 27 | 2021 | 1920 | 0.950 |
Why?
|
Ribavirin | 15 | 2012 | 57 | 0.950 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2020 | 878 | 0.940 |
Why?
|
Quinazolines | 7 | 2016 | 220 | 0.940 |
Why?
|
Diabetic Nephropathies | 7 | 2011 | 248 | 0.940 |
Why?
|
Crohn Disease | 11 | 2016 | 730 | 0.940 |
Why?
|
Estrogen Receptor alpha | 5 | 2020 | 144 | 0.930 |
Why?
|
Vaccination | 8 | 2020 | 254 | 0.920 |
Why?
|
HEK293 Cells | 19 | 2020 | 615 | 0.920 |
Why?
|
Cell Nucleus | 7 | 2018 | 579 | 0.920 |
Why?
|
Chromosomes, Human, Pair 9 | 8 | 2018 | 86 | 0.920 |
Why?
|
NIH 3T3 Cells | 21 | 2020 | 105 | 0.920 |
Why?
|
Chromosomes, Human, Pair 5 | 13 | 2014 | 109 | 0.920 |
Why?
|
Neoplasm Staging | 17 | 2022 | 1939 | 0.910 |
Why?
|
Obesity | 9 | 2012 | 963 | 0.910 |
Why?
|
DNA Damage | 16 | 2017 | 366 | 0.900 |
Why?
|
Protein-Arginine N-Methyltransferases | 5 | 2015 | 12 | 0.900 |
Why?
|
Receptors, Estrogen | 11 | 2020 | 384 | 0.900 |
Why?
|
Xenograft Model Antitumor Assays | 13 | 2021 | 458 | 0.890 |
Why?
|
Introns | 21 | 2012 | 289 | 0.890 |
Why?
|
Lupus Erythematosus, Systemic | 9 | 2013 | 206 | 0.890 |
Why?
|
Amino Acid Substitution | 18 | 2019 | 339 | 0.880 |
Why?
|
Frizzled Receptors | 7 | 2021 | 15 | 0.860 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 5 | 2013 | 13 | 0.860 |
Why?
|
Cell Adhesion Molecules | 5 | 2009 | 163 | 0.860 |
Why?
|
Receptors, Antigen, B-Cell | 4 | 2021 | 113 | 0.850 |
Why?
|
Glycoproteins | 7 | 2011 | 234 | 0.850 |
Why?
|
Chemotherapy, Adjuvant | 10 | 2016 | 468 | 0.840 |
Why?
|
Genotyping Techniques | 5 | 2016 | 68 | 0.840 |
Why?
|
Hepacivirus | 15 | 2013 | 159 | 0.820 |
Why?
|
Cell Cycle | 21 | 2016 | 502 | 0.820 |
Why?
|
Genetic Therapy | 5 | 2021 | 342 | 0.820 |
Why?
|
Proto-Oncogene Proteins | 14 | 2012 | 645 | 0.810 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 6 | 2021 | 42 | 0.800 |
Why?
|
Thiophenes | 3 | 2019 | 48 | 0.800 |
Why?
|
Bronchi | 5 | 2017 | 229 | 0.790 |
Why?
|
Esophagectomy | 1 | 2022 | 84 | 0.790 |
Why?
|
Quinolones | 3 | 2019 | 60 | 0.790 |
Why?
|
Risk Factors | 48 | 2024 | 5417 | 0.780 |
Why?
|
Cytoskeletal Proteins | 11 | 2011 | 223 | 0.780 |
Why?
|
Liquid Biopsy | 5 | 2021 | 33 | 0.780 |
Why?
|
Gene Expression | 28 | 2017 | 1284 | 0.770 |
Why?
|
Taxoids | 3 | 2016 | 129 | 0.770 |
Why?
|
Sentinel Lymph Node | 1 | 2020 | 15 | 0.760 |
Why?
|
DNA, Neoplasm | 10 | 2016 | 265 | 0.760 |
Why?
|
Nevirapine | 2 | 2011 | 5 | 0.760 |
Why?
|
Cell Line | 38 | 2013 | 2468 | 0.760 |
Why?
|
Plasma | 1 | 2020 | 50 | 0.750 |
Why?
|
Immunogenetics | 2 | 2021 | 9 | 0.750 |
Why?
|
Serum | 1 | 2020 | 25 | 0.750 |
Why?
|
Quantitative Trait Loci | 12 | 2021 | 576 | 0.750 |
Why?
|
Fibroblasts | 8 | 2016 | 729 | 0.750 |
Why?
|
Peptide Fragments | 13 | 2018 | 460 | 0.740 |
Why?
|
Ascites | 1 | 2020 | 55 | 0.740 |
Why?
|
Cell Division | 12 | 2011 | 696 | 0.740 |
Why?
|
Kaplan-Meier Estimate | 15 | 2018 | 860 | 0.730 |
Why?
|
Immunoprecipitation | 18 | 2015 | 134 | 0.730 |
Why?
|
Databases, Genetic | 9 | 2021 | 260 | 0.730 |
Why?
|
Cell Movement | 11 | 2020 | 758 | 0.730 |
Why?
|
HeLa Cells | 16 | 2016 | 498 | 0.720 |
Why?
|
Life Style | 6 | 2017 | 189 | 0.720 |
Why?
|
DNA Repair | 6 | 2014 | 356 | 0.720 |
Why?
|
DNA Primers | 24 | 2012 | 543 | 0.710 |
Why?
|
HSP90 Heat-Shock Proteins | 3 | 2018 | 46 | 0.710 |
Why?
|
Inventions | 1 | 2019 | 13 | 0.700 |
Why?
|
Preoperative Care | 1 | 2022 | 397 | 0.700 |
Why?
|
Transcriptional Activation | 20 | 2016 | 280 | 0.700 |
Why?
|
Testis | 8 | 2014 | 152 | 0.690 |
Why?
|
Pneumonectomy | 2 | 2013 | 196 | 0.690 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2017 | 128 | 0.690 |
Why?
|
SOXB1 Transcription Factors | 1 | 2019 | 21 | 0.690 |
Why?
|
Myocardial Infarction | 9 | 2014 | 376 | 0.680 |
Why?
|
Cluster Analysis | 15 | 2014 | 369 | 0.680 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2019 | 1313 | 0.680 |
Why?
|
Disease-Free Survival | 12 | 2022 | 1204 | 0.680 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 3 | 2010 | 199 | 0.680 |
Why?
|
Odds Ratio | 23 | 2018 | 678 | 0.670 |
Why?
|
Carcinoma | 9 | 2021 | 436 | 0.670 |
Why?
|
Oxidoreductases, N-Demethylating | 3 | 2018 | 14 | 0.670 |
Why?
|
Genetic Markers | 19 | 2013 | 476 | 0.670 |
Why?
|
Collagen | 5 | 2011 | 269 | 0.670 |
Why?
|
Phosphoproteins | 5 | 2011 | 254 | 0.660 |
Why?
|
Cytochrome P-450 Enzyme System | 4 | 2016 | 79 | 0.660 |
Why?
|
Immunogenetic Phenomena | 1 | 2018 | 5 | 0.660 |
Why?
|
HLA-A24 Antigen | 14 | 2018 | 20 | 0.660 |
Why?
|
Cadherins | 5 | 2016 | 151 | 0.650 |
Why?
|
Reproducibility of Results | 23 | 2016 | 2705 | 0.650 |
Why?
|
Chromosomes, Human, Pair 8 | 7 | 2013 | 85 | 0.650 |
Why?
|
Algorithms | 11 | 2019 | 1830 | 0.640 |
Why?
|
Radioimmunotherapy | 6 | 2021 | 25 | 0.640 |
Why?
|
Antibodies, Monoclonal | 9 | 2018 | 1376 | 0.640 |
Why?
|
Carcinoma, Small Cell | 5 | 2010 | 134 | 0.640 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2018 | 66 | 0.640 |
Why?
|
Calcium-Binding Proteins | 3 | 2016 | 115 | 0.630 |
Why?
|
Interferons | 14 | 2012 | 133 | 0.630 |
Why?
|
Genes, p53 | 9 | 2008 | 109 | 0.630 |
Why?
|
Immunotherapy, Adoptive | 6 | 2022 | 170 | 0.630 |
Why?
|
E2F1 Transcription Factor | 5 | 2014 | 13 | 0.630 |
Why?
|
Blood Proteins | 4 | 2012 | 144 | 0.630 |
Why?
|
Fibronectins | 4 | 2016 | 93 | 0.620 |
Why?
|
Peanut Hypersensitivity | 1 | 2017 | 15 | 0.620 |
Why?
|
Chromosomes, Human, Pair 10 | 6 | 2013 | 47 | 0.620 |
Why?
|
Glycosylation | 10 | 2019 | 129 | 0.620 |
Why?
|
Granulocyte Colony-Stimulating Factor | 2 | 2016 | 165 | 0.620 |
Why?
|
Chromosomes, Human, Pair 12 | 7 | 2021 | 65 | 0.620 |
Why?
|
Pharmacogenomic Variants | 1 | 2017 | 41 | 0.620 |
Why?
|
Neutropenia | 3 | 2013 | 215 | 0.610 |
Why?
|
Chromosomes, Human, Pair 14 | 3 | 2012 | 49 | 0.610 |
Why?
|
Lymphatic Metastasis | 13 | 2022 | 486 | 0.610 |
Why?
|
Glucuronosyltransferase | 3 | 2012 | 184 | 0.600 |
Why?
|
Postmenopause | 6 | 2017 | 98 | 0.600 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2010 | 106 | 0.600 |
Why?
|
Hydrolases | 5 | 2012 | 28 | 0.600 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 3 | 2012 | 24 | 0.590 |
Why?
|
Homeodomain Proteins | 9 | 2018 | 536 | 0.590 |
Why?
|
Nitriles | 5 | 2014 | 149 | 0.590 |
Why?
|
Oncogene Proteins | 5 | 2018 | 59 | 0.590 |
Why?
|
Triazoles | 5 | 2014 | 96 | 0.580 |
Why?
|
HLA-B Antigens | 4 | 2020 | 35 | 0.580 |
Why?
|
Genetics, Population | 18 | 2013 | 394 | 0.580 |
Why?
|
Amyotrophic Lateral Sclerosis | 6 | 2018 | 182 | 0.580 |
Why?
|
DNA Copy Number Variations | 6 | 2020 | 171 | 0.580 |
Why?
|
Duodenal Ulcer | 2 | 2013 | 11 | 0.580 |
Why?
|
Mannosyltransferases | 1 | 2016 | 6 | 0.580 |
Why?
|
Polymyositis | 1 | 2016 | 6 | 0.580 |
Why?
|
Young Adult | 34 | 2020 | 5976 | 0.580 |
Why?
|
Enzyme Activation | 12 | 2016 | 692 | 0.580 |
Why?
|
Cytokinesis | 2 | 2014 | 57 | 0.570 |
Why?
|
Interferon Type I | 5 | 2023 | 175 | 0.570 |
Why?
|
Cholangiocarcinoma | 6 | 2010 | 66 | 0.570 |
Why?
|
Pulmonary Veins | 1 | 2017 | 72 | 0.570 |
Why?
|
Phenotype | 22 | 2021 | 2378 | 0.560 |
Why?
|
Hepatitis C | 8 | 2013 | 208 | 0.560 |
Why?
|
Bile Duct Neoplasms | 6 | 2010 | 79 | 0.560 |
Why?
|
RNA-Binding Proteins | 9 | 2018 | 246 | 0.560 |
Why?
|
Intercellular Signaling Peptides and Proteins | 8 | 2010 | 179 | 0.560 |
Why?
|
DNA Mutational Analysis | 12 | 2018 | 526 | 0.550 |
Why?
|
Anticoagulants | 3 | 2013 | 408 | 0.550 |
Why?
|
Cell Growth Processes | 13 | 2012 | 83 | 0.550 |
Why?
|
Imidazoles | 2 | 2015 | 162 | 0.550 |
Why?
|
Acyltransferases | 2 | 2013 | 41 | 0.550 |
Why?
|
Trachea | 1 | 2017 | 293 | 0.540 |
Why?
|
Myasthenia Gravis | 1 | 2016 | 83 | 0.540 |
Why?
|
Anemia | 5 | 2023 | 128 | 0.540 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2012 | 683 | 0.540 |
Why?
|
Disease Progression | 18 | 2016 | 1531 | 0.540 |
Why?
|
Deoxycytidine | 7 | 2018 | 237 | 0.540 |
Why?
|
Gene Expression Regulation, Enzymologic | 7 | 2016 | 214 | 0.540 |
Why?
|
Gene Dosage | 6 | 2014 | 207 | 0.540 |
Why?
|
Cohort Studies | 26 | 2020 | 2767 | 0.530 |
Why?
|
Mesothelioma | 2 | 2016 | 311 | 0.530 |
Why?
|
Receptor, Endothelin A | 2 | 2012 | 22 | 0.530 |
Why?
|
Unrelated Donors | 1 | 2015 | 50 | 0.520 |
Why?
|
Nasopharyngeal Neoplasms | 5 | 2016 | 47 | 0.520 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2015 | 127 | 0.520 |
Why?
|
Pyrophosphatases | 6 | 2011 | 16 | 0.510 |
Why?
|
Smoking | 8 | 2017 | 609 | 0.510 |
Why?
|
HIV Infections | 4 | 2011 | 772 | 0.510 |
Why?
|
Multidrug Resistance-Associated Proteins | 3 | 2011 | 27 | 0.510 |
Why?
|
Endometrial Neoplasms | 2 | 2017 | 193 | 0.510 |
Why?
|
Poly(ADP-ribose) Polymerases | 2 | 2014 | 46 | 0.510 |
Why?
|
L-Selectin | 3 | 2006 | 16 | 0.510 |
Why?
|
Viral Core Proteins | 8 | 2012 | 27 | 0.510 |
Why?
|
Aminopyridines | 1 | 2015 | 38 | 0.510 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 12 | 2012 | 376 | 0.510 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 6 | 2015 | 74 | 0.510 |
Why?
|
Cornified Envelope Proline-Rich Proteins | 1 | 2014 | 6 | 0.510 |
Why?
|
Helicobacter Infections | 2 | 2018 | 34 | 0.500 |
Why?
|
Genetic Testing | 11 | 2021 | 535 | 0.490 |
Why?
|
Keloid | 2 | 2011 | 8 | 0.490 |
Why?
|
Anthracenes | 2 | 2013 | 16 | 0.490 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2014 | 33 | 0.490 |
Why?
|
Exons | 16 | 2012 | 450 | 0.490 |
Why?
|
Adenoma | 3 | 2013 | 235 | 0.490 |
Why?
|
Graft vs Host Disease | 4 | 2020 | 365 | 0.480 |
Why?
|
Risk | 11 | 2014 | 674 | 0.480 |
Why?
|
Neoadjuvant Therapy | 5 | 2022 | 318 | 0.480 |
Why?
|
Sarcoma, Endometrial Stromal | 1 | 2013 | 8 | 0.480 |
Why?
|
Adaptor Proteins, Signal Transducing | 8 | 2015 | 302 | 0.480 |
Why?
|
Gene Library | 4 | 2003 | 130 | 0.480 |
Why?
|
Sulfonamides | 2 | 2013 | 300 | 0.480 |
Why?
|
Polyethylene Glycols | 8 | 2012 | 363 | 0.480 |
Why?
|
Patient Selection | 2 | 2016 | 685 | 0.470 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 3 | 2020 | 113 | 0.470 |
Why?
|
Leukocytes | 6 | 2014 | 202 | 0.460 |
Why?
|
Chromosomes, Human, Pair 17 | 4 | 2012 | 110 | 0.460 |
Why?
|
Chromosomes, Human, Pair 13 | 9 | 2013 | 51 | 0.460 |
Why?
|
Thailand | 8 | 2012 | 66 | 0.460 |
Why?
|
Phenanthrolines | 1 | 2013 | 7 | 0.460 |
Why?
|
Helicobacter pylori | 1 | 2013 | 35 | 0.460 |
Why?
|
E-Selectin | 3 | 2006 | 30 | 0.460 |
Why?
|
Immunoenzyme Techniques | 13 | 2012 | 303 | 0.450 |
Why?
|
Coordination Complexes | 1 | 2013 | 19 | 0.450 |
Why?
|
Zinc Fingers | 5 | 2013 | 56 | 0.450 |
Why?
|
Germ-Line Mutation | 7 | 2021 | 329 | 0.450 |
Why?
|
Aromatase Inhibitors | 5 | 2014 | 28 | 0.450 |
Why?
|
Adrenergic alpha-1 Receptor Antagonists | 1 | 2012 | 8 | 0.450 |
Why?
|
Edetic Acid | 1 | 2013 | 43 | 0.450 |
Why?
|
Dose-Response Relationship, Drug | 15 | 2019 | 1961 | 0.450 |
Why?
|
Alopecia | 1 | 2013 | 34 | 0.450 |
Why?
|
Tissue Distribution | 11 | 2023 | 290 | 0.450 |
Why?
|
Tenascin | 3 | 2007 | 8 | 0.450 |
Why?
|
Chromosomes, Mammalian | 1 | 2013 | 36 | 0.450 |
Why?
|
Binding Sites | 19 | 2016 | 1098 | 0.450 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2013 | 113 | 0.440 |
Why?
|
Interleukin-2 | 2 | 2011 | 249 | 0.440 |
Why?
|
Cytoplasm | 5 | 2017 | 281 | 0.440 |
Why?
|
Vestibule, Labyrinth | 2 | 2003 | 44 | 0.440 |
Why?
|
Platinum | 1 | 2013 | 63 | 0.440 |
Why?
|
Models, Genetic | 13 | 2016 | 926 | 0.440 |
Why?
|
Doxorubicin | 8 | 2015 | 295 | 0.440 |
Why?
|
Sulfotransferases | 4 | 2016 | 19 | 0.440 |
Why?
|
Serum Albumin | 2 | 2012 | 130 | 0.440 |
Why?
|
Mixed Function Oxygenases | 5 | 2013 | 68 | 0.440 |
Why?
|
Protein Transport | 9 | 2017 | 411 | 0.440 |
Why?
|
Follow-Up Studies | 13 | 2022 | 3640 | 0.430 |
Why?
|
Annexin A3 | 1 | 2012 | 1 | 0.430 |
Why?
|
Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2012 | 1 | 0.430 |
Why?
|
Zinc | 1 | 2013 | 91 | 0.430 |
Why?
|
Transmembrane Activator and CAML Interactor Protein | 1 | 2012 | 8 | 0.430 |
Why?
|
Paralysis, Hyperkalemic Periodic | 1 | 2012 | 1 | 0.430 |
Why?
|
Mammary Glands, Human | 2 | 2014 | 22 | 0.430 |
Why?
|
Nuclear Envelope | 1 | 2012 | 36 | 0.430 |
Why?
|
Histocompatibility Antigens Class II | 4 | 2020 | 158 | 0.430 |
Why?
|
Forkhead Box Protein M1 | 6 | 2017 | 13 | 0.430 |
Why?
|
Camptothecin | 3 | 2009 | 189 | 0.430 |
Why?
|
Cytochrome P-450 CYP2D6 Inhibitors | 2 | 2011 | 5 | 0.420 |
Why?
|
Brain Neoplasms | 3 | 2009 | 763 | 0.420 |
Why?
|
HLA-DR Antigens | 5 | 2009 | 61 | 0.420 |
Why?
|
Gallbladder Neoplasms | 1 | 2012 | 22 | 0.420 |
Why?
|
Glaucoma, Open-Angle | 1 | 2012 | 17 | 0.420 |
Why?
|
Antibodies | 3 | 2012 | 350 | 0.420 |
Why?
|
Genetics, Medical | 2 | 2010 | 52 | 0.420 |
Why?
|
Endometriosis | 3 | 2012 | 58 | 0.420 |
Why?
|
Paclitaxel | 5 | 2015 | 460 | 0.420 |
Why?
|
Tissue Extracts | 1 | 2011 | 24 | 0.420 |
Why?
|
Dermatitis, Atopic | 4 | 2013 | 52 | 0.420 |
Why?
|
Benzoxazines | 1 | 2011 | 4 | 0.420 |
Why?
|
Biomarkers | 9 | 2018 | 1718 | 0.410 |
Why?
|
Chromosomes, Human, Pair 22 | 5 | 2011 | 43 | 0.410 |
Why?
|
Thyroid Neoplasms | 3 | 2015 | 408 | 0.410 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2011 | 23 | 0.410 |
Why?
|
Schizophrenia | 2 | 2013 | 464 | 0.410 |
Why?
|
Myelodysplastic Syndromes | 1 | 2015 | 346 | 0.410 |
Why?
|
Hyperthyroidism | 1 | 2012 | 75 | 0.410 |
Why?
|
Tissue Array Analysis | 13 | 2016 | 124 | 0.410 |
Why?
|
Leukocyte Count | 6 | 2016 | 220 | 0.410 |
Why?
|
Melanoma | 1 | 2016 | 459 | 0.410 |
Why?
|
Prospective Studies | 10 | 2022 | 4213 | 0.400 |
Why?
|
Antibiotics, Antineoplastic | 6 | 2015 | 114 | 0.400 |
Why?
|
Models, Biological | 10 | 2017 | 1749 | 0.400 |
Why?
|
Recombinant Proteins | 17 | 2014 | 1014 | 0.400 |
Why?
|
Prostatic Hyperplasia | 1 | 2012 | 88 | 0.400 |
Why?
|
Patient Care | 1 | 2012 | 100 | 0.400 |
Why?
|
Liver | 10 | 2016 | 1230 | 0.400 |
Why?
|
Vitamin K Epoxide Reductases | 5 | 2019 | 16 | 0.400 |
Why?
|
Epithelial Cells | 8 | 2017 | 669 | 0.400 |
Why?
|
Drug Eruptions | 1 | 2011 | 35 | 0.400 |
Why?
|
Lim Kinases | 1 | 2011 | 3 | 0.400 |
Why?
|
Cytochrome P-450 CYP2C9 | 5 | 2019 | 21 | 0.400 |
Why?
|
HLA-DP Antigens | 4 | 2011 | 9 | 0.400 |
Why?
|
Neoplasm Invasiveness | 6 | 2020 | 552 | 0.400 |
Why?
|
beta Catenin | 10 | 2011 | 251 | 0.390 |
Why?
|
Mice, Inbred BALB C | 18 | 2018 | 1047 | 0.390 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 3 | 2023 | 34 | 0.390 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2011 | 15 | 0.390 |
Why?
|
Computational Biology | 10 | 2017 | 528 | 0.390 |
Why?
|
Mitochondrial Proteins | 4 | 2010 | 123 | 0.390 |
Why?
|
Logistic Models | 11 | 2013 | 1186 | 0.390 |
Why?
|
Skin Neoplasms | 1 | 2016 | 546 | 0.390 |
Why?
|
Organic Anion Transporters | 2 | 2008 | 27 | 0.390 |
Why?
|
Carbamazepine | 1 | 2010 | 10 | 0.390 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2011 | 44 | 0.390 |
Why?
|
Cell Survival | 16 | 2017 | 969 | 0.390 |
Why?
|
Sirtuin 1 | 1 | 2011 | 32 | 0.390 |
Why?
|
Membrane Transport Proteins | 4 | 2012 | 166 | 0.380 |
Why?
|
Body Mass Index | 6 | 2012 | 770 | 0.380 |
Why?
|
Antineoplastic Agents, Phytogenic | 4 | 2015 | 276 | 0.380 |
Why?
|
RNA, Antisense | 1 | 2010 | 15 | 0.380 |
Why?
|
Nerve Tissue Proteins | 6 | 2012 | 503 | 0.380 |
Why?
|
Polyglutamic Acid | 1 | 2010 | 15 | 0.380 |
Why?
|
Peptide Synthases | 1 | 2010 | 12 | 0.380 |
Why?
|
Multigene Family | 7 | 2014 | 202 | 0.370 |
Why?
|
Epigenesis, Genetic | 5 | 2018 | 479 | 0.370 |
Why?
|
Mice, Nude | 14 | 2018 | 790 | 0.370 |
Why?
|
Aspirin | 4 | 2017 | 156 | 0.370 |
Why?
|
Acetyl-CoA Carboxylase | 1 | 2010 | 24 | 0.370 |
Why?
|
Adolescent | 30 | 2020 | 8981 | 0.370 |
Why?
|
Organ Specificity | 9 | 2014 | 258 | 0.370 |
Why?
|
MCF-7 Cells | 6 | 2016 | 106 | 0.370 |
Why?
|
Cyclophosphamide | 3 | 2018 | 299 | 0.360 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2010 | 69 | 0.360 |
Why?
|
Child | 24 | 2017 | 6927 | 0.360 |
Why?
|
Aldehyde Dehydrogenase | 3 | 2009 | 14 | 0.360 |
Why?
|
Lectins, C-Type | 5 | 2011 | 85 | 0.360 |
Why?
|
Uterine Neoplasms | 1 | 2013 | 227 | 0.360 |
Why?
|
Gamma Rays | 5 | 2014 | 72 | 0.360 |
Why?
|
Chromosomes, Human, Pair 11 | 5 | 2012 | 106 | 0.360 |
Why?
|
Plagiarism | 1 | 2009 | 8 | 0.360 |
Why?
|
Anticonvulsants | 1 | 2010 | 126 | 0.360 |
Why?
|
Scientific Misconduct | 1 | 2009 | 10 | 0.360 |
Why?
|
Papillomavirus Infections | 4 | 2023 | 239 | 0.360 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2017 | 378 | 0.350 |
Why?
|
Alcohol Dehydrogenase | 3 | 2009 | 42 | 0.350 |
Why?
|
Receptor, ErbB-2 | 5 | 2020 | 223 | 0.350 |
Why?
|
Morphogenesis | 1 | 2011 | 192 | 0.350 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2017 | 567 | 0.350 |
Why?
|
Proteinuria | 1 | 2010 | 107 | 0.350 |
Why?
|
Predictive Value of Tests | 10 | 2011 | 1673 | 0.350 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2009 | 3 | 0.350 |
Why?
|
Receptors, Drug | 3 | 2005 | 54 | 0.350 |
Why?
|
Receptors, Serotonin | 1 | 2009 | 34 | 0.350 |
Why?
|
Retinoblastoma Protein | 4 | 2015 | 66 | 0.350 |
Why?
|
Chlamydophila Infections | 1 | 2009 | 3 | 0.350 |
Why?
|
Principal Component Analysis | 5 | 2014 | 155 | 0.350 |
Why?
|
Chlamydophila pneumoniae | 1 | 2009 | 12 | 0.340 |
Why?
|
Gene Silencing | 10 | 2016 | 172 | 0.340 |
Why?
|
Transforming Growth Factor alpha | 2 | 2006 | 50 | 0.340 |
Why?
|
rab GTP-Binding Proteins | 1 | 2009 | 26 | 0.340 |
Why?
|
Flow Cytometry | 15 | 2014 | 679 | 0.340 |
Why?
|
Testicular Neoplasms | 3 | 2005 | 105 | 0.340 |
Why?
|
Loss of Heterozygosity | 4 | 2014 | 85 | 0.340 |
Why?
|
Chromosomes, Human, Pair 3 | 8 | 2012 | 54 | 0.340 |
Why?
|
Child, Preschool | 16 | 2017 | 3612 | 0.340 |
Why?
|
Cells, Cultured | 18 | 2018 | 2818 | 0.330 |
Why?
|
Antigens, CD | 3 | 2019 | 458 | 0.330 |
Why?
|
Time Factors | 16 | 2016 | 5210 | 0.330 |
Why?
|
Major Histocompatibility Complex | 5 | 2021 | 81 | 0.330 |
Why?
|
Exanthema | 1 | 2009 | 36 | 0.330 |
Why?
|
Structure-Activity Relationship | 5 | 2015 | 408 | 0.330 |
Why?
|
Peripheral Nervous System Diseases | 3 | 2015 | 85 | 0.330 |
Why?
|
Proliferating Cell Nuclear Antigen | 3 | 2017 | 66 | 0.330 |
Why?
|
Histone Demethylases | 3 | 2015 | 30 | 0.330 |
Why?
|
PTEN Phosphohydrolase | 5 | 2020 | 128 | 0.330 |
Why?
|
Bone Marrow Cells | 3 | 2016 | 253 | 0.330 |
Why?
|
Mass Spectrometry | 9 | 2015 | 188 | 0.330 |
Why?
|
Organic Anion Transporters, Sodium-Independent | 1 | 2008 | 5 | 0.320 |
Why?
|
Drug Screening Assays, Antitumor | 6 | 2016 | 78 | 0.320 |
Why?
|
Genes, Tumor Suppressor | 9 | 2015 | 157 | 0.320 |
Why?
|
HLA-DRB1 Chains | 7 | 2013 | 28 | 0.320 |
Why?
|
Proteasome Endopeptidase Complex | 5 | 2013 | 100 | 0.320 |
Why?
|
Muscular Diseases | 1 | 2008 | 63 | 0.320 |
Why?
|
Anticarcinogenic Agents | 2 | 2013 | 70 | 0.320 |
Why?
|
Cation Transport Proteins | 3 | 2007 | 64 | 0.320 |
Why?
|
Cisplatin | 8 | 2014 | 612 | 0.320 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2022 | 13 | 0.320 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2015 | 262 | 0.320 |
Why?
|
Carbon-Carbon Ligases | 1 | 2007 | 2 | 0.310 |
Why?
|
Simvastatin | 1 | 2008 | 106 | 0.310 |
Why?
|
HCT116 Cells | 9 | 2016 | 151 | 0.310 |
Why?
|
Piperazines | 3 | 2007 | 272 | 0.310 |
Why?
|
Protein-Arginine Deiminases | 6 | 2018 | 6 | 0.310 |
Why?
|
Peritoneal Neoplasms | 2 | 2020 | 177 | 0.310 |
Why?
|
Cell Membrane Permeability | 4 | 2018 | 119 | 0.310 |
Why?
|
CD4-Positive T-Lymphocytes | 4 | 2017 | 425 | 0.310 |
Why?
|
Immune Tolerance | 2 | 2009 | 337 | 0.310 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2003 | 173 | 0.310 |
Why?
|
Metalloendopeptidases | 2 | 2004 | 45 | 0.310 |
Why?
|
Toxicogenetics | 1 | 2007 | 1 | 0.310 |
Why?
|
Survival Rate | 7 | 2020 | 1863 | 0.310 |
Why?
|
Kidney | 10 | 2016 | 1241 | 0.310 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2018 | 276 | 0.310 |
Why?
|
Drug Discovery | 2 | 2021 | 103 | 0.310 |
Why?
|
Metabolic Syndrome | 1 | 2009 | 141 | 0.310 |
Why?
|
Pyrimidines | 4 | 2007 | 370 | 0.300 |
Why?
|
Abnormalities, Multiple | 1 | 2009 | 232 | 0.300 |
Why?
|
Seminoma | 2 | 2004 | 10 | 0.300 |
Why?
|
Retrospective Studies | 12 | 2021 | 8489 | 0.300 |
Why?
|
Chromatin | 6 | 2014 | 380 | 0.300 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2007 | 37 | 0.300 |
Why?
|
RNA | 7 | 2016 | 560 | 0.300 |
Why?
|
Leiomyoma | 1 | 2011 | 191 | 0.300 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2017 | 153 | 0.300 |
Why?
|
Protein Isoforms | 7 | 2011 | 270 | 0.300 |
Why?
|
Osteosarcoma | 2 | 2009 | 158 | 0.300 |
Why?
|
Blood Coagulation | 1 | 2007 | 91 | 0.300 |
Why?
|
Neuroblastoma | 2 | 2019 | 374 | 0.300 |
Why?
|
Betacoronavirus | 2 | 2020 | 258 | 0.300 |
Why?
|
Opisthorchiasis | 1 | 2006 | 1 | 0.300 |
Why?
|
Oligopeptides | 4 | 2012 | 179 | 0.290 |
Why?
|
Tandem Repeat Sequences | 2 | 2009 | 26 | 0.290 |
Why?
|
Oxidoreductases | 2 | 2015 | 112 | 0.290 |
Why?
|
Apoptosis Regulatory Proteins | 7 | 2012 | 199 | 0.290 |
Why?
|
Hepatitis B, Chronic | 3 | 2012 | 32 | 0.290 |
Why?
|
Survival Analysis | 11 | 2020 | 1538 | 0.290 |
Why?
|
Membrane Glycoproteins | 7 | 2012 | 428 | 0.290 |
Why?
|
MutS Homolog 2 Protein | 2 | 2021 | 30 | 0.290 |
Why?
|
Carcinogenesis | 5 | 2020 | 195 | 0.290 |
Why?
|
Fibroblast Growth Factors | 2 | 2005 | 80 | 0.290 |
Why?
|
rhoA GTP-Binding Protein | 2 | 2009 | 83 | 0.290 |
Why?
|
Mice, Knockout | 12 | 2020 | 1924 | 0.290 |
Why?
|
Chromosomes, Human, Pair 4 | 5 | 2012 | 48 | 0.290 |
Why?
|
Cytokines | 7 | 2018 | 776 | 0.290 |
Why?
|
Mitochondria | 6 | 2008 | 535 | 0.280 |
Why?
|
Radiation Tolerance | 2 | 2009 | 168 | 0.280 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2023 | 350 | 0.280 |
Why?
|
HLA-A2 Antigen | 6 | 2014 | 31 | 0.280 |
Why?
|
Neoplasms, Second Primary | 1 | 2009 | 252 | 0.280 |
Why?
|
Mice, SCID | 6 | 2016 | 252 | 0.280 |
Why?
|
Bipolar Disorder | 1 | 2009 | 377 | 0.280 |
Why?
|
Cyclins | 2 | 2003 | 82 | 0.280 |
Why?
|
Estrogens | 3 | 2020 | 200 | 0.280 |
Why?
|
Homozygote | 7 | 2012 | 200 | 0.280 |
Why?
|
Disease | 2 | 2017 | 90 | 0.280 |
Why?
|
Genes, Reporter | 6 | 2014 | 268 | 0.280 |
Why?
|
Immunoglobulins | 2 | 2012 | 148 | 0.280 |
Why?
|
Neoplasm Metastasis | 8 | 2020 | 1056 | 0.280 |
Why?
|
Genome | 4 | 2004 | 372 | 0.280 |
Why?
|
Brain Ischemia | 3 | 2010 | 398 | 0.280 |
Why?
|
Genetic Linkage | 9 | 2010 | 623 | 0.280 |
Why?
|
Cell Differentiation | 8 | 2018 | 1458 | 0.280 |
Why?
|
Cochlea | 2 | 2003 | 50 | 0.280 |
Why?
|
Chromosomes, Human, Pair 7 | 4 | 2013 | 79 | 0.270 |
Why?
|
Stroke | 3 | 2010 | 965 | 0.270 |
Why?
|
Coculture Techniques | 3 | 2022 | 164 | 0.270 |
Why?
|
Proportional Hazards Models | 9 | 2017 | 859 | 0.270 |
Why?
|
Cytochrome P450 Family 4 | 2 | 2019 | 2 | 0.270 |
Why?
|
Contractile Proteins | 1 | 2005 | 54 | 0.270 |
Why?
|
Models, Statistical | 6 | 2016 | 574 | 0.270 |
Why?
|
Genes, MHC Class II | 2 | 2003 | 30 | 0.270 |
Why?
|
Obesity, Morbid | 1 | 2008 | 225 | 0.270 |
Why?
|
Protein Interaction Domains and Motifs | 2 | 2017 | 86 | 0.270 |
Why?
|
Intestinal Neoplasms | 2 | 2008 | 56 | 0.260 |
Why?
|
KCNQ1 Potassium Channel | 3 | 2010 | 16 | 0.260 |
Why?
|
Prostatic Neoplasms, Castration-Resistant | 2 | 2017 | 111 | 0.260 |
Why?
|
Osteoarthritis, Knee | 4 | 2010 | 63 | 0.260 |
Why?
|
Galectin 1 | 1 | 2004 | 6 | 0.260 |
Why?
|
rho GTP-Binding Proteins | 1 | 2005 | 54 | 0.260 |
Why?
|
Adenosine Triphosphatases | 3 | 2018 | 153 | 0.260 |
Why?
|
gamma-Glutamyltransferase | 2 | 2010 | 16 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 301 | 0.260 |
Why?
|
Dinucleoside Phosphates | 1 | 2004 | 9 | 0.260 |
Why?
|
Cholesterol | 2 | 2017 | 356 | 0.260 |
Why?
|
Spike Glycoprotein, Coronavirus | 2 | 2022 | 40 | 0.250 |
Why?
|
Meta-Analysis as Topic | 6 | 2021 | 87 | 0.250 |
Why?
|
RNA Splice Sites | 3 | 2012 | 53 | 0.250 |
Why?
|
Lung | 9 | 2018 | 1170 | 0.250 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2004 | 21 | 0.250 |
Why?
|
Point Mutation | 2 | 2015 | 246 | 0.250 |
Why?
|
Severity of Illness Index | 8 | 2018 | 1801 | 0.250 |
Why?
|
GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2004 | 3 | 0.250 |
Why?
|
Neuropeptides | 3 | 2013 | 112 | 0.250 |
Why?
|
Bile Ducts, Intrahepatic | 5 | 2010 | 70 | 0.250 |
Why?
|
MutL Protein Homolog 1 | 3 | 2021 | 33 | 0.250 |
Why?
|
Protein Multimerization | 2 | 2017 | 173 | 0.250 |
Why?
|
Colitis, Ulcerative | 4 | 2013 | 711 | 0.250 |
Why?
|
Pharmacokinetics | 1 | 2004 | 12 | 0.250 |
Why?
|
Chromosome Banding | 1 | 2004 | 74 | 0.250 |
Why?
|
Receptors, Calcitriol | 2 | 2018 | 129 | 0.250 |
Why?
|
Bronchodilator Agents | 3 | 2013 | 65 | 0.250 |
Why?
|
Depressive Disorder, Major | 2 | 2018 | 158 | 0.240 |
Why?
|
Electrophoretic Mobility Shift Assay | 12 | 2013 | 72 | 0.240 |
Why?
|
Histone Deacetylases | 1 | 2004 | 63 | 0.240 |
Why?
|
Multiple Myeloma | 2 | 2019 | 307 | 0.240 |
Why?
|
Tumor Burden | 3 | 2021 | 289 | 0.240 |
Why?
|
Drug Administration Schedule | 5 | 2016 | 916 | 0.240 |
Why?
|
Medical Oncology | 1 | 2008 | 359 | 0.240 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 4 | 2017 | 91 | 0.240 |
Why?
|
Extracellular Matrix Proteins | 5 | 2009 | 123 | 0.240 |
Why?
|
Cartilage, Articular | 2 | 2010 | 67 | 0.240 |
Why?
|
Yttrium Radioisotopes | 3 | 2021 | 46 | 0.240 |
Why?
|
Kruppel-Like Transcription Factors | 3 | 2012 | 93 | 0.240 |
Why?
|
Receptors, Steroid | 2 | 2016 | 42 | 0.240 |
Why?
|
BRCA1 Protein | 2 | 2017 | 200 | 0.240 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2005 | 243 | 0.240 |
Why?
|
Cartilage | 2 | 2003 | 113 | 0.230 |
Why?
|
Risk Assessment | 7 | 2017 | 2261 | 0.230 |
Why?
|
Receptors, Polymeric Immunoglobulin | 1 | 2003 | 5 | 0.230 |
Why?
|
Antibodies, Monoclonal, Humanized | 2 | 2021 | 930 | 0.230 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2003 | 46 | 0.230 |
Why?
|
Hematinics | 1 | 2023 | 11 | 0.230 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 3 | 2016 | 81 | 0.230 |
Why?
|
Esterases | 1 | 2003 | 12 | 0.230 |
Why?
|
Enzyme-Linked Immunospot Assay | 2 | 2020 | 7 | 0.230 |
Why?
|
Proteomics | 5 | 2018 | 212 | 0.230 |
Why?
|
Chelating Agents | 1 | 2023 | 69 | 0.230 |
Why?
|
Ligases | 1 | 2003 | 45 | 0.230 |
Why?
|
DNA Replication | 5 | 2017 | 164 | 0.230 |
Why?
|
Embryonic Stem Cells | 2 | 2018 | 78 | 0.230 |
Why?
|
Rats | 8 | 2015 | 3990 | 0.230 |
Why?
|
Ovarian Cysts | 1 | 2003 | 17 | 0.230 |
Why?
|
CpG Islands | 1 | 2003 | 151 | 0.230 |
Why?
|
Disease Susceptibility | 7 | 2010 | 193 | 0.230 |
Why?
|
Transglutaminases | 1 | 2003 | 39 | 0.230 |
Why?
|
Antimetabolites, Antineoplastic | 4 | 2018 | 236 | 0.230 |
Why?
|
Ovarian Diseases | 1 | 2003 | 32 | 0.230 |
Why?
|
Hearing Loss | 1 | 2003 | 56 | 0.230 |
Why?
|
Crystallins | 1 | 2002 | 5 | 0.230 |
Why?
|
Receptors, Immunologic | 3 | 2009 | 135 | 0.230 |
Why?
|
Remission Induction | 4 | 2021 | 722 | 0.230 |
Why?
|
Bulgaria | 3 | 2013 | 3 | 0.220 |
Why?
|
Erythropoietin | 1 | 2023 | 91 | 0.220 |
Why?
|
Substrate Specificity | 3 | 2018 | 347 | 0.220 |
Why?
|
Deafness | 1 | 2002 | 47 | 0.220 |
Why?
|
Mice, Inbred NOD | 5 | 2016 | 187 | 0.220 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2003 | 36 | 0.220 |
Why?
|
Mitosis | 2 | 2015 | 153 | 0.220 |
Why?
|
RNA-Binding Protein EWS | 4 | 2018 | 7 | 0.220 |
Why?
|
Oxonic Acid | 4 | 2012 | 8 | 0.220 |
Why?
|
Tegafur | 4 | 2012 | 17 | 0.220 |
Why?
|
Chromosomes, Human, Pair 15 | 5 | 2014 | 63 | 0.220 |
Why?
|
Cell Death | 3 | 2014 | 256 | 0.220 |
Why?
|
Sensitivity and Specificity | 8 | 2019 | 1991 | 0.220 |
Why?
|
Gene Deletion | 4 | 2007 | 329 | 0.220 |
Why?
|
Nephrolithiasis | 2 | 2013 | 22 | 0.220 |
Why?
|
Oligonucleotides, Antisense | 6 | 2005 | 69 | 0.220 |
Why?
|
Administration, Oral | 4 | 2015 | 684 | 0.220 |
Why?
|
Homeostasis | 2 | 2015 | 409 | 0.220 |
Why?
|
Sulindac | 1 | 2002 | 10 | 0.220 |
Why?
|
Polysaccharides | 3 | 2012 | 89 | 0.220 |
Why?
|
Isoenzymes | 3 | 2013 | 271 | 0.220 |
Why?
|
Arginine | 4 | 2015 | 136 | 0.210 |
Why?
|
Autoimmune Diseases | 2 | 2018 | 241 | 0.210 |
Why?
|
Adenocarcinoma, Mucinous | 4 | 2012 | 48 | 0.210 |
Why?
|
Mice, Inbred C57BL | 11 | 2020 | 3092 | 0.210 |
Why?
|
Estradiol | 3 | 2013 | 252 | 0.210 |
Why?
|
Actinium | 1 | 2021 | 1 | 0.210 |
Why?
|
Cytodiagnosis | 2 | 2019 | 42 | 0.210 |
Why?
|
Cell- and Tissue-Based Therapy | 1 | 2022 | 49 | 0.210 |
Why?
|
ROC Curve | 7 | 2014 | 752 | 0.210 |
Why?
|
Luciferases | 9 | 2013 | 118 | 0.210 |
Why?
|
Ascorbic Acid | 1 | 2002 | 37 | 0.210 |
Why?
|
Granuloma | 2 | 2019 | 65 | 0.210 |
Why?
|
ras Guanine Nucleotide Exchange Factors | 3 | 2013 | 8 | 0.210 |
Why?
|
Oncogenes | 3 | 2007 | 88 | 0.210 |
Why?
|
Drug Combinations | 5 | 2012 | 224 | 0.210 |
Why?
|
BCG Vaccine | 2 | 2020 | 31 | 0.210 |
Why?
|
Transcription Factor TFIIIA | 2 | 2012 | 2 | 0.210 |
Why?
|
Lymphocytes | 2 | 2022 | 464 | 0.210 |
Why?
|
Carcinoma, Ductal | 1 | 2021 | 18 | 0.210 |
Why?
|
Knee Joint | 1 | 2003 | 168 | 0.210 |
Why?
|
Schizosaccharomyces pombe Proteins | 1 | 2002 | 35 | 0.210 |
Why?
|
Actins | 2 | 2020 | 451 | 0.210 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2018 | 138 | 0.210 |
Why?
|
Protein Structure, Tertiary | 10 | 2012 | 736 | 0.210 |
Why?
|
Drug Therapy, Combination | 9 | 2018 | 894 | 0.210 |
Why?
|
Microfilament Proteins | 6 | 2013 | 208 | 0.200 |
Why?
|
Real-Time Polymerase Chain Reaction | 7 | 2018 | 273 | 0.200 |
Why?
|
Chromosomal Instability | 2 | 2014 | 19 | 0.200 |
Why?
|
beta-Defensins | 2 | 2018 | 12 | 0.200 |
Why?
|
Cloning, Molecular | 7 | 2012 | 646 | 0.200 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 6 | 2014 | 74 | 0.200 |
Why?
|
Osteoporosis | 2 | 2014 | 121 | 0.200 |
Why?
|
MAP Kinase Signaling System | 5 | 2015 | 192 | 0.200 |
Why?
|
Enhancer Elements, Genetic | 1 | 2003 | 266 | 0.200 |
Why?
|
Mesoderm | 1 | 2002 | 108 | 0.200 |
Why?
|
Fucose | 2 | 2012 | 13 | 0.200 |
Why?
|
Fungal Proteins | 1 | 2002 | 141 | 0.200 |
Why?
|
Sequence Homology, Amino Acid | 5 | 2005 | 416 | 0.200 |
Why?
|
TCF Transcription Factors | 4 | 2005 | 23 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-ets | 3 | 2013 | 25 | 0.200 |
Why?
|
RNA, Neoplasm | 4 | 2016 | 87 | 0.200 |
Why?
|
Stavudine | 2 | 2011 | 4 | 0.200 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2012 | 104 | 0.200 |
Why?
|
Osteoarthritis | 3 | 2007 | 73 | 0.200 |
Why?
|
Antigen Presentation | 2 | 2020 | 209 | 0.200 |
Why?
|
Neoplasm Grading | 2 | 2020 | 357 | 0.200 |
Why?
|
Calcium Channels | 2 | 2013 | 182 | 0.200 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 4 | 2 | 2012 | 9 | 0.200 |
Why?
|
Histocompatibility Antigens | 2 | 2011 | 35 | 0.200 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2020 | 31 | 0.190 |
Why?
|
Dyslipidemias | 2 | 2017 | 109 | 0.190 |
Why?
|
Rectal Neoplasms | 3 | 2019 | 116 | 0.190 |
Why?
|
Oncogene Proteins, Viral | 1 | 2020 | 34 | 0.190 |
Why?
|
Chromatin Immunoprecipitation | 8 | 2016 | 133 | 0.190 |
Why?
|
Cellular Senescence | 3 | 2012 | 94 | 0.190 |
Why?
|
Enzyme Inhibitors | 4 | 2018 | 639 | 0.190 |
Why?
|
Models, Molecular | 3 | 2015 | 1286 | 0.190 |
Why?
|
CA-125 Antigen | 1 | 2020 | 22 | 0.190 |
Why?
|
Immunity, Cellular | 1 | 2021 | 177 | 0.190 |
Why?
|
Vaginal Neoplasms | 1 | 2020 | 83 | 0.190 |
Why?
|
Biosensing Techniques | 2 | 2020 | 68 | 0.190 |
Why?
|
DNA Fragmentation | 1 | 2020 | 63 | 0.190 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2016 | 375 | 0.190 |
Why?
|
Transforming Growth Factor beta | 6 | 2011 | 301 | 0.190 |
Why?
|
Biological Assay | 2 | 2010 | 78 | 0.190 |
Why?
|
Carcinogens | 1 | 2020 | 108 | 0.190 |
Why?
|
Mucin-1 | 2 | 2010 | 44 | 0.190 |
Why?
|
CD8 Antigens | 2 | 2017 | 82 | 0.190 |
Why?
|
Cyclin-Dependent Kinase 5 | 2 | 2012 | 12 | 0.190 |
Why?
|
Blood | 1 | 2020 | 69 | 0.190 |
Why?
|
Ubiquitin-Conjugating Enzymes | 2 | 2010 | 30 | 0.190 |
Why?
|
3' Untranslated Regions | 6 | 2009 | 92 | 0.190 |
Why?
|
GPI-Linked Proteins | 8 | 2013 | 50 | 0.190 |
Why?
|
Myofibroblasts | 1 | 2020 | 43 | 0.190 |
Why?
|
Aging | 2 | 2016 | 691 | 0.190 |
Why?
|
Recombinant Fusion Proteins | 7 | 2017 | 557 | 0.180 |
Why?
|
Granzymes | 2 | 2017 | 93 | 0.180 |
Why?
|
Herpesvirus 1, Human | 2 | 2018 | 244 | 0.180 |
Why?
|
5' Untranslated Regions | 4 | 2012 | 49 | 0.180 |
Why?
|
Viral Vaccines | 1 | 2020 | 43 | 0.180 |
Why?
|
Autocrine Communication | 1 | 2019 | 18 | 0.180 |
Why?
|
Breast | 2 | 2019 | 288 | 0.180 |
Why?
|
Open Reading Frames | 1 | 2020 | 117 | 0.180 |
Why?
|
Platelet Membrane Glycoprotein IIb | 2 | 2014 | 5 | 0.180 |
Why?
|
Coronavirus | 1 | 2020 | 19 | 0.180 |
Why?
|
Th1 Cells | 2 | 2018 | 164 | 0.180 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2020 | 154 | 0.180 |
Why?
|
Urinary Bladder | 3 | 2018 | 246 | 0.180 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 56 | 0.180 |
Why?
|
Bone and Bones | 2 | 2013 | 265 | 0.180 |
Why?
|
Antigens, Ly | 3 | 2008 | 37 | 0.180 |
Why?
|
Molecular Structure | 3 | 2015 | 287 | 0.180 |
Why?
|
NF-kappa B | 6 | 2012 | 444 | 0.180 |
Why?
|
Peptides, Cyclic | 2 | 2009 | 43 | 0.180 |
Why?
|
Datasets as Topic | 1 | 2019 | 71 | 0.180 |
Why?
|
Erlotinib Hydrochloride | 2 | 2017 | 90 | 0.180 |
Why?
|
STAT3 Transcription Factor | 3 | 2015 | 78 | 0.180 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 2 | 2011 | 20 | 0.180 |
Why?
|
Cathepsins | 2 | 2013 | 21 | 0.180 |
Why?
|
Protons | 1 | 2020 | 98 | 0.180 |
Why?
|
5' Flanking Region | 5 | 2007 | 16 | 0.180 |
Why?
|
Lung Abscess | 1 | 2019 | 5 | 0.180 |
Why?
|
Gene Rearrangement | 1 | 2020 | 170 | 0.180 |
Why?
|
Protein Kinase C | 2 | 2013 | 270 | 0.180 |
Why?
|
HSP70 Heat-Shock Proteins | 3 | 2012 | 113 | 0.180 |
Why?
|
Stem Cells | 1 | 2002 | 351 | 0.170 |
Why?
|
DNA Mismatch Repair | 2 | 2021 | 52 | 0.170 |
Why?
|
Sodium | 2 | 2011 | 341 | 0.170 |
Why?
|
Neoplasms, Glandular and Epithelial | 2 | 2017 | 74 | 0.170 |
Why?
|
Coumarins | 1 | 2019 | 13 | 0.170 |
Why?
|
Genetic Vectors | 7 | 2016 | 439 | 0.170 |
Why?
|
Serpins | 2 | 2012 | 29 | 0.170 |
Why?
|
Osteoarthritis, Hip | 3 | 2010 | 23 | 0.170 |
Why?
|
Selective Estrogen Receptor Modulators | 3 | 2015 | 34 | 0.170 |
Why?
|
Potassium Channels, Inwardly Rectifying | 2 | 2012 | 119 | 0.170 |
Why?
|
Protein Interaction Mapping | 3 | 2011 | 82 | 0.170 |
Why?
|
Hemoglobins | 3 | 2023 | 179 | 0.170 |
Why?
|
Population Groups | 4 | 2012 | 41 | 0.170 |
Why?
|
Antineoplastic Agents, Immunological | 2 | 2018 | 185 | 0.170 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2020 | 157 | 0.170 |
Why?
|
Brain | 4 | 2020 | 2216 | 0.170 |
Why?
|
Lymphocyte Activation | 5 | 2018 | 728 | 0.170 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2018 | 32 | 0.170 |
Why?
|
Cytotoxins | 1 | 2018 | 15 | 0.170 |
Why?
|
Sesquiterpenes | 1 | 2018 | 13 | 0.170 |
Why?
|
Astatine | 1 | 2018 | 3 | 0.170 |
Why?
|
Raloxifene Hydrochloride | 3 | 2015 | 10 | 0.170 |
Why?
|
Forkhead Transcription Factors | 4 | 2016 | 166 | 0.170 |
Why?
|
RNA, Untranslated | 2 | 2010 | 63 | 0.170 |
Why?
|
Genetic Techniques | 2 | 2009 | 72 | 0.160 |
Why?
|
Combined Modality Therapy | 9 | 2018 | 1686 | 0.160 |
Why?
|
Radioisotopes | 1 | 2018 | 45 | 0.160 |
Why?
|
Macrophages | 2 | 2020 | 554 | 0.160 |
Why?
|
Receptors, IgG | 3 | 2013 | 52 | 0.160 |
Why?
|
Sialoglycoproteins | 2 | 2010 | 31 | 0.160 |
Why?
|
Autoantigens | 5 | 2013 | 127 | 0.160 |
Why?
|
Regression Analysis | 3 | 2013 | 596 | 0.160 |
Why?
|
Software | 5 | 2011 | 654 | 0.160 |
Why?
|
Microsomes, Liver | 2 | 2015 | 49 | 0.160 |
Why?
|
Hepatitis B virus | 3 | 2012 | 43 | 0.160 |
Why?
|
Oncolytic Viruses | 1 | 2018 | 23 | 0.160 |
Why?
|
Receptors, Progesterone | 4 | 2020 | 167 | 0.160 |
Why?
|
Immunoglobulin M | 1 | 2018 | 154 | 0.160 |
Why?
|
Europe | 4 | 2013 | 309 | 0.160 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2018 | 15 | 0.160 |
Why?
|
Response Evaluation Criteria in Solid Tumors | 1 | 2018 | 56 | 0.160 |
Why?
|
eIF-2 Kinase | 2 | 2015 | 46 | 0.160 |
Why?
|
Hypertension, Pulmonary | 1 | 2022 | 346 | 0.160 |
Why?
|
Kynurenine | 1 | 2018 | 20 | 0.160 |
Why?
|
Lymph Node Excision | 3 | 2014 | 217 | 0.160 |
Why?
|
Translocation, Genetic | 2 | 2016 | 265 | 0.160 |
Why?
|
Acetylation | 3 | 2015 | 121 | 0.160 |
Why?
|
Artificial Intelligence | 2 | 2019 | 298 | 0.160 |
Why?
|
Mediastinal Cyst | 1 | 2017 | 3 | 0.160 |
Why?
|
Bronchogenic Cyst | 1 | 2017 | 5 | 0.160 |
Why?
|
Uric Acid | 3 | 2012 | 139 | 0.160 |
Why?
|
Calmodulin | 2 | 2010 | 50 | 0.150 |
Why?
|
Nod2 Signaling Adaptor Protein | 2 | 2011 | 13 | 0.150 |
Why?
|
Cyanobacteria | 1 | 2018 | 111 | 0.150 |
Why?
|
Fever | 1 | 2018 | 125 | 0.150 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2015 | 68 | 0.150 |
Why?
|
Papillomaviridae | 2 | 2017 | 153 | 0.150 |
Why?
|
Estrone | 1 | 2017 | 10 | 0.150 |
Why?
|
Interferon-gamma | 7 | 2018 | 444 | 0.150 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 136 | 0.150 |
Why?
|
Citalopram | 2 | 2014 | 20 | 0.150 |
Why?
|
United Kingdom | 3 | 2010 | 164 | 0.150 |
Why?
|
CD11c Antigen | 1 | 2017 | 11 | 0.150 |
Why?
|
Thy-1 Antigens | 1 | 2017 | 16 | 0.150 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2017 | 22 | 0.150 |
Why?
|
Early Growth Response Protein 2 | 2 | 2010 | 17 | 0.150 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2010 | 279 | 0.150 |
Why?
|
Gene Transfer Techniques | 3 | 2008 | 152 | 0.150 |
Why?
|
Endoscopy | 1 | 2020 | 332 | 0.150 |
Why?
|
Chromosomes, Human, Pair 2 | 3 | 2012 | 85 | 0.150 |
Why?
|
Cardiovascular Diseases | 3 | 2017 | 827 | 0.150 |
Why?
|
Ubiquitination | 3 | 2015 | 67 | 0.150 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2017 | 30 | 0.150 |
Why?
|
Telomere Homeostasis | 1 | 2017 | 30 | 0.150 |
Why?
|
Lasers | 4 | 2005 | 106 | 0.150 |
Why?
|
Artifacts | 2 | 2016 | 244 | 0.150 |
Why?
|
Lectins | 3 | 2012 | 84 | 0.150 |
Why?
|
Pleckstrin Homology Domains | 1 | 2016 | 1 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 3 | 2017 | 2601 | 0.150 |
Why?
|
Chloride Channels | 2 | 2019 | 42 | 0.150 |
Why?
|
Mendelian Randomization Analysis | 1 | 2017 | 43 | 0.150 |
Why?
|
Diabetic Neuropathies | 2 | 2007 | 40 | 0.150 |
Why?
|
Butyrylcholinesterase | 1 | 2016 | 10 | 0.150 |
Why?
|
Thrombosis | 2 | 2010 | 296 | 0.150 |
Why?
|
Expressed Sequence Tags | 4 | 2004 | 35 | 0.150 |
Why?
|
Epilepsy | 1 | 2021 | 397 | 0.150 |
Why?
|
Spheroids, Cellular | 1 | 2017 | 31 | 0.150 |
Why?
|
Serine | 4 | 2011 | 99 | 0.150 |
Why?
|
Caspases | 4 | 2005 | 155 | 0.150 |
Why?
|
Respiratory Tract Diseases | 1 | 2017 | 45 | 0.150 |
Why?
|
RNA Helicases | 2 | 2009 | 35 | 0.150 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 44 | 0.150 |
Why?
|
Clinical Trials, Phase III as Topic | 3 | 2011 | 172 | 0.150 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 64 | 0.140 |
Why?
|
Azacitidine | 2 | 2014 | 137 | 0.140 |
Why?
|
Proteolysis | 3 | 2012 | 100 | 0.140 |
Why?
|
Interleukin-17 | 3 | 2012 | 101 | 0.140 |
Why?
|
Dyneins | 1 | 2016 | 14 | 0.140 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2016 | 25 | 0.140 |
Why?
|
Cystatins | 2 | 2008 | 5 | 0.140 |
Why?
|
Kinetics | 3 | 2005 | 1513 | 0.140 |
Why?
|
Netrin Receptors | 2 | 2014 | 6 | 0.140 |
Why?
|
Organic Cation Transport Proteins | 2 | 2008 | 13 | 0.140 |
Why?
|
Hyperlipidemias | 1 | 2017 | 95 | 0.140 |
Why?
|
Prostate-Specific Antigen | 3 | 2017 | 353 | 0.140 |
Why?
|
Histocompatibility Testing | 1 | 2016 | 154 | 0.140 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 165 | 0.140 |
Why?
|
Polycomb Repressive Complex 2 | 2 | 2013 | 30 | 0.140 |
Why?
|
Sex Factors | 4 | 2020 | 1054 | 0.140 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2016 | 4 | 0.140 |
Why?
|
Cathepsin L | 1 | 2016 | 7 | 0.140 |
Why?
|
Stress, Physiological | 2 | 2017 | 227 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-myc | 3 | 2012 | 120 | 0.140 |
Why?
|
A549 Cells | 1 | 2016 | 39 | 0.140 |
Why?
|
Receptor, ErbB-3 | 1 | 2016 | 18 | 0.140 |
Why?
|
Glycolysis | 1 | 2017 | 129 | 0.140 |
Why?
|
Subcellular Fractions | 2 | 2007 | 93 | 0.140 |
Why?
|
Monitoring, Immunologic | 2 | 2014 | 17 | 0.140 |
Why?
|
B7-H1 Antigen | 1 | 2018 | 250 | 0.140 |
Why?
|
Cystatin C | 1 | 2016 | 31 | 0.140 |
Why?
|
Solubility | 2 | 2015 | 177 | 0.140 |
Why?
|
Neovascularization, Pathologic | 3 | 2012 | 353 | 0.140 |
Why?
|
Plasma Cells | 1 | 2016 | 80 | 0.140 |
Why?
|
Iron-Sulfur Proteins | 1 | 2015 | 11 | 0.140 |
Why?
|
Vinblastine | 2 | 2007 | 108 | 0.140 |
Why?
|
DEAD-box RNA Helicases | 2 | 2015 | 62 | 0.140 |
Why?
|
U937 Cells | 1 | 2015 | 32 | 0.140 |
Why?
|
Registries | 2 | 2017 | 702 | 0.140 |
Why?
|
Receptor, EphA4 | 2 | 2006 | 5 | 0.140 |
Why?
|
Polyneuropathies | 1 | 2016 | 27 | 0.140 |
Why?
|
Myocarditis | 1 | 2016 | 50 | 0.140 |
Why?
|
Vascular Diseases | 1 | 2017 | 121 | 0.140 |
Why?
|
Ipilimumab | 1 | 2016 | 58 | 0.140 |
Why?
|
3T3 Cells | 3 | 2005 | 94 | 0.140 |
Why?
|
Metabolic Networks and Pathways | 2 | 2013 | 79 | 0.140 |
Why?
|
Shoulder | 1 | 2016 | 42 | 0.140 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 2 | 2005 | 20 | 0.140 |
Why?
|
Urothelium | 1 | 2016 | 70 | 0.140 |
Why?
|
Ribonucleotide Reductases | 2 | 2007 | 6 | 0.140 |
Why?
|
Heat-Shock Proteins | 1 | 2017 | 179 | 0.140 |
Why?
|
Cause of Death | 4 | 2017 | 277 | 0.140 |
Why?
|
Chromatography, Liquid | 3 | 2011 | 104 | 0.130 |
Why?
|
Plasmids | 6 | 2007 | 287 | 0.130 |
Why?
|
Incidence | 6 | 2019 | 1577 | 0.130 |
Why?
|
Graft vs Leukemia Effect | 1 | 2015 | 11 | 0.130 |
Why?
|
Machine Learning | 1 | 2017 | 232 | 0.130 |
Why?
|
Protein Stability | 2 | 2017 | 99 | 0.130 |
Why?
|
Sarcoma, Ewing | 3 | 2005 | 42 | 0.130 |
Why?
|
Complementarity Determining Regions | 1 | 2015 | 24 | 0.130 |
Why?
|
In Situ Hybridization, Fluorescence | 5 | 2007 | 348 | 0.130 |
Why?
|
Methotrexate | 2 | 2007 | 249 | 0.130 |
Why?
|
Pharmaceutical Preparations | 1 | 2016 | 92 | 0.130 |
Why?
|
Kidney Transplantation | 2 | 2016 | 849 | 0.130 |
Why?
|
Glypicans | 3 | 2011 | 6 | 0.130 |
Why?
|
Multivariate Analysis | 5 | 2014 | 999 | 0.130 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2015 | 90 | 0.130 |
Why?
|
Drug Stability | 1 | 2015 | 48 | 0.130 |
Why?
|
Urologic Neoplasms | 1 | 2016 | 77 | 0.130 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2016 | 87 | 0.130 |
Why?
|
Transcriptome | 2 | 2017 | 580 | 0.130 |
Why?
|
Fatal Outcome | 1 | 2016 | 293 | 0.130 |
Why?
|
Pyridazines | 1 | 2015 | 22 | 0.130 |
Why?
|
Saccharomyces cerevisiae | 1 | 2018 | 434 | 0.130 |
Why?
|
Receptors, Androgen | 3 | 2010 | 113 | 0.130 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 316 | 0.130 |
Why?
|
Poly (ADP-Ribose) Polymerase-1 | 2 | 2014 | 21 | 0.130 |
Why?
|
Withholding Treatment | 1 | 2016 | 112 | 0.130 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2016 | 112 | 0.130 |
Why?
|
Serine Proteases | 1 | 2014 | 4 | 0.130 |
Why?
|
Iron | 1 | 2015 | 164 | 0.130 |
Why?
|
Age Factors | 6 | 2020 | 1851 | 0.130 |
Why?
|
Transcription Factor 7-Like 2 Protein | 3 | 2003 | 29 | 0.130 |
Why?
|
Cytochrome P-450 CYP2C19 | 1 | 2014 | 7 | 0.130 |
Why?
|
Killer Cells, Natural | 2 | 2009 | 267 | 0.130 |
Why?
|
Adaptor Protein Complex delta Subunits | 1 | 2014 | 1 | 0.130 |
Why?
|
Adaptor Protein Complex 3 | 1 | 2014 | 2 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 2014 | 10 | 0.130 |
Why?
|
In Situ Hybridization | 3 | 2005 | 307 | 0.130 |
Why?
|
Chemoradiotherapy | 1 | 2017 | 301 | 0.130 |
Why?
|
Liposomes | 1 | 2014 | 91 | 0.130 |
Why?
|
GATA Transcription Factors | 1 | 2014 | 4 | 0.130 |
Why?
|
Bevacizumab | 3 | 2024 | 281 | 0.120 |
Why?
|
Molecular Epidemiology | 2 | 2011 | 53 | 0.120 |
Why?
|
GTP-Binding Proteins | 3 | 2011 | 146 | 0.120 |
Why?
|
Viral Nonstructural Proteins | 2 | 2011 | 37 | 0.120 |
Why?
|
Receptors, Interleukin-17 | 2 | 2012 | 10 | 0.120 |
Why?
|
Vaccines, Combined | 1 | 2014 | 5 | 0.120 |
Why?
|
Hepatitis B | 2 | 2012 | 74 | 0.120 |
Why?
|
Pleural Neoplasms | 2 | 2008 | 188 | 0.120 |
Why?
|
Allografts | 1 | 2015 | 172 | 0.120 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2015 | 100 | 0.120 |
Why?
|
Tumor Stem Cell Assay | 2 | 2004 | 35 | 0.120 |
Why?
|
Smad7 Protein | 1 | 2014 | 7 | 0.120 |
Why?
|
RNA Stability | 4 | 2007 | 86 | 0.120 |
Why?
|
Graves Disease | 2 | 2011 | 36 | 0.120 |
Why?
|
Dysostoses | 1 | 2013 | 1 | 0.120 |
Why?
|
Minisatellite Repeats | 4 | 2012 | 24 | 0.120 |
Why?
|
HLA-DQ beta-Chains | 1 | 2013 | 12 | 0.120 |
Why?
|
Receptors, Ghrelin | 2 | 2011 | 4 | 0.120 |
Why?
|
Indazoles | 1 | 2014 | 68 | 0.120 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2013 | 21 | 0.120 |
Why?
|
Adnexa Uteri | 1 | 2013 | 12 | 0.120 |
Why?
|
Torsades de Pointes | 1 | 2013 | 7 | 0.120 |
Why?
|
Quality of Life | 2 | 2013 | 1585 | 0.120 |
Why?
|
Autoantibodies | 3 | 2013 | 267 | 0.120 |
Why?
|
Sequence Alignment | 4 | 2014 | 351 | 0.120 |
Why?
|
C-Reactive Protein | 2 | 2014 | 190 | 0.120 |
Why?
|
Angioedema | 1 | 2013 | 4 | 0.120 |
Why?
|
ABO Blood-Group System | 3 | 2021 | 62 | 0.120 |
Why?
|
Telomerase | 2 | 2012 | 55 | 0.120 |
Why?
|
Osteoporotic Fractures | 1 | 2014 | 38 | 0.120 |
Why?
|
Chemoradiotherapy, Adjuvant | 1 | 2013 | 35 | 0.120 |
Why?
|
Ramipril | 1 | 2013 | 12 | 0.120 |
Why?
|
Tandem Mass Spectrometry | 5 | 2013 | 103 | 0.120 |
Why?
|
Hep G2 Cells | 4 | 2018 | 48 | 0.120 |
Why?
|
Neuropeptide Y | 1 | 2013 | 31 | 0.120 |
Why?
|
Carcinoma, Adenosquamous | 3 | 2014 | 12 | 0.120 |
Why?
|
Tumor Escape | 2 | 2015 | 49 | 0.120 |
Why?
|
Bone Neoplasms | 2 | 2009 | 322 | 0.120 |
Why?
|
Neprilysin | 1 | 2013 | 42 | 0.120 |
Why?
|
Viral Load | 5 | 2011 | 148 | 0.120 |
Why?
|
Chromosomes, Human, Pair 19 | 2 | 2011 | 59 | 0.120 |
Why?
|
Rabbits | 7 | 2010 | 636 | 0.120 |
Why?
|
Lymphotoxin-alpha | 2 | 2004 | 44 | 0.120 |
Why?
|
Estrogen Antagonists | 1 | 2013 | 48 | 0.120 |
Why?
|
Malaysia | 4 | 2016 | 12 | 0.120 |
Why?
|
Phosphoric Monoester Hydrolases | 2 | 2004 | 51 | 0.120 |
Why?
|
Interleukin-6 | 2 | 2014 | 256 | 0.120 |
Why?
|
Stomach Ulcer | 1 | 2013 | 23 | 0.120 |
Why?
|
Thorax | 1 | 2013 | 75 | 0.120 |
Why?
|
Pelvis | 1 | 2013 | 95 | 0.120 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2013 | 58 | 0.120 |
Why?
|
Receptor, Melanocortin, Type 4 | 2 | 2010 | 4 | 0.120 |
Why?
|
HTLV-I Infections | 1 | 2013 | 7 | 0.120 |
Why?
|
Infant | 5 | 2012 | 3046 | 0.120 |
Why?
|
Catalogs as Topic | 2 | 2004 | 2 | 0.120 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2013 | 14 | 0.120 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2013 | 16 | 0.120 |
Why?
|
Neoplasm Transplantation | 3 | 2020 | 391 | 0.120 |
Why?
|
Aromatase | 1 | 2013 | 12 | 0.110 |
Why?
|
Gluconeogenesis | 1 | 2013 | 14 | 0.110 |
Why?
|
Menarche | 1 | 2013 | 24 | 0.110 |
Why?
|
Kv Channel-Interacting Proteins | 1 | 2013 | 9 | 0.110 |
Why?
|
Sp3 Transcription Factor | 1 | 2013 | 2 | 0.110 |
Why?
|
Molecular Conformation | 1 | 2013 | 96 | 0.110 |
Why?
|
Physical Chromosome Mapping | 1 | 2013 | 27 | 0.110 |
Why?
|
RNA, Viral | 5 | 2012 | 327 | 0.110 |
Why?
|
Cell-Penetrating Peptides | 1 | 2013 | 3 | 0.110 |
Why?
|
Hydroxylation | 1 | 2013 | 16 | 0.110 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2010 | 115 | 0.110 |
Why?
|
Histidine | 1 | 2013 | 55 | 0.110 |
Why?
|
Glucose | 2 | 2013 | 638 | 0.110 |
Why?
|
Protein Array Analysis | 2 | 2012 | 50 | 0.110 |
Why?
|
Haptoglobins | 1 | 2012 | 9 | 0.110 |
Why?
|
Untranslated Regions | 2 | 2003 | 19 | 0.110 |
Why?
|
Tubulin Modulators | 1 | 2013 | 24 | 0.110 |
Why?
|
Methyltransferases | 1 | 2014 | 182 | 0.110 |
Why?
|
Guanine Nucleotide Exchange Factors | 2 | 2010 | 73 | 0.110 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 579 | 0.110 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2012 | 12 | 0.110 |
Why?
|
Oligosaccharides | 1 | 2012 | 24 | 0.110 |
Why?
|
Testosterone | 2 | 2012 | 271 | 0.110 |
Why?
|
Cell Membrane | 4 | 2016 | 666 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 30 | 0.110 |
Why?
|
Hysterectomy | 1 | 2013 | 146 | 0.110 |
Why?
|
I-kappa B Proteins | 1 | 2012 | 53 | 0.110 |
Why?
|
RNA, Ribosomal | 1 | 2012 | 60 | 0.110 |
Why?
|
Blood Glucose | 1 | 2017 | 873 | 0.110 |
Why?
|
Body Height | 2 | 2010 | 99 | 0.110 |
Why?
|
Genes, APC | 2 | 2002 | 26 | 0.110 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2012 | 2 | 0.110 |
Why?
|
Sarcoma | 2 | 2013 | 215 | 0.110 |
Why?
|
Universities | 1 | 2013 | 135 | 0.110 |
Why?
|
Calpain | 1 | 2013 | 111 | 0.110 |
Why?
|
MicroRNAs | 1 | 2017 | 534 | 0.110 |
Why?
|
DNA Polymerase III | 1 | 2012 | 9 | 0.110 |
Why?
|
Glycine Dehydrogenase | 1 | 2012 | 1 | 0.110 |
Why?
|
Pyrazoles | 1 | 2013 | 153 | 0.110 |
Why?
|
Annexin A4 | 1 | 2012 | 2 | 0.110 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2012 | 23 | 0.110 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2012 | 39 | 0.110 |
Why?
|
Lentivirus | 2 | 2009 | 36 | 0.110 |
Why?
|
DCC Receptor | 1 | 2012 | 4 | 0.110 |
Why?
|
Musculoskeletal Pain | 1 | 2012 | 10 | 0.110 |
Why?
|
Bacterial Proteins | 1 | 2018 | 864 | 0.110 |
Why?
|
Ankyrins | 1 | 2012 | 23 | 0.110 |
Why?
|
Caspase 3 | 2 | 2010 | 159 | 0.110 |
Why?
|
Atherosclerosis | 3 | 2010 | 244 | 0.110 |
Why?
|
Gout | 1 | 2012 | 76 | 0.110 |
Why?
|
Sensory Receptor Cells | 1 | 2012 | 35 | 0.110 |
Why?
|
Transaminases | 1 | 2012 | 34 | 0.110 |
Why?
|
Adrenal Cortex Hormones | 1 | 2013 | 263 | 0.110 |
Why?
|
Macular Degeneration | 1 | 2013 | 59 | 0.110 |
Why?
|
Jurkat Cells | 6 | 2009 | 77 | 0.110 |
Why?
|
Receptors, Retinoic Acid | 1 | 2012 | 45 | 0.110 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2012 | 85 | 0.110 |
Why?
|
Chemokine CCL22 | 1 | 2011 | 5 | 0.110 |
Why?
|
Rats, Sprague-Dawley | 1 | 2015 | 1219 | 0.100 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 231 | 0.100 |
Why?
|
Drug Hypersensitivity | 2 | 2009 | 37 | 0.100 |
Why?
|
Microarray Analysis | 4 | 2017 | 96 | 0.100 |
Why?
|
Megakaryocytes | 1 | 2011 | 36 | 0.100 |
Why?
|
Zimbabwe | 1 | 2011 | 3 | 0.100 |
Why?
|
Glycine | 1 | 2012 | 92 | 0.100 |
Why?
|
Cytochrome P-450 CYP2B6 | 1 | 2011 | 6 | 0.100 |
Why?
|
Epirubicin | 1 | 2011 | 14 | 0.100 |
Why?
|
Cyclopropanes | 1 | 2011 | 25 | 0.100 |
Why?
|
Alkynes | 1 | 2011 | 17 | 0.100 |
Why?
|
HLA-B52 Antigen | 1 | 2011 | 1 | 0.100 |
Why?
|
Lamivudine | 1 | 2011 | 13 | 0.100 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 2 | 2010 | 9 | 0.100 |
Why?
|
Aurora Kinases | 2 | 2012 | 17 | 0.100 |
Why?
|
Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 2 | 2010 | 41 | 0.100 |
Why?
|
Reference Values | 3 | 2012 | 674 | 0.100 |
Why?
|
Aurora Kinase B | 2 | 2012 | 14 | 0.100 |
Why?
|
Crystallography, X-Ray | 1 | 2013 | 485 | 0.100 |
Why?
|
China | 4 | 2014 | 228 | 0.100 |
Why?
|
Microsatellite Repeats | 3 | 2017 | 145 | 0.100 |
Why?
|
Enhancer of Zeste Homolog 2 Protein | 3 | 2020 | 35 | 0.100 |
Why?
|
Hydroxymethyl and Formyl Transferases | 1 | 2011 | 1 | 0.100 |
Why?
|
HLA-C Antigens | 1 | 2011 | 21 | 0.100 |
Why?
|
Ghrelin | 1 | 2011 | 29 | 0.100 |
Why?
|
Pedigree | 4 | 2012 | 966 | 0.100 |
Why?
|
Enzymes | 1 | 2011 | 47 | 0.100 |
Why?
|
Sequence Deletion | 1 | 2012 | 205 | 0.100 |
Why?
|
HLA-DQ Antigens | 1 | 2011 | 52 | 0.100 |
Why?
|
Wet Macular Degeneration | 1 | 2011 | 25 | 0.100 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2011 | 54 | 0.100 |
Why?
|
Clinical Trials as Topic | 4 | 2020 | 1169 | 0.100 |
Why?
|
Blood Platelets | 1 | 2011 | 149 | 0.100 |
Why?
|
Drug Prescriptions | 1 | 2012 | 141 | 0.100 |
Why?
|
Blood Pressure | 1 | 2017 | 1143 | 0.100 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2008 | 112 | 0.100 |
Why?
|
Cell Extracts | 1 | 2011 | 15 | 0.100 |
Why?
|
Nedd4 Ubiquitin Protein Ligases | 1 | 2011 | 14 | 0.100 |
Why?
|
Nephrotic Syndrome | 1 | 2011 | 33 | 0.100 |
Why?
|
Myosin-Light-Chain Phosphatase | 1 | 2010 | 8 | 0.100 |
Why?
|
Glioblastoma | 2 | 2004 | 255 | 0.100 |
Why?
|
Gene Products, tax | 1 | 2010 | 4 | 0.100 |
Why?
|
Gastric Mucosa | 1 | 2011 | 66 | 0.100 |
Why?
|
GRB10 Adaptor Protein | 1 | 2010 | 1 | 0.100 |
Why?
|
Paroxetine | 1 | 2011 | 26 | 0.100 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2011 | 36 | 0.100 |
Why?
|
Tumor Necrosis Factor Ligand Superfamily Member 15 | 2 | 2013 | 6 | 0.100 |
Why?
|
Exonucleases | 1 | 2010 | 8 | 0.100 |
Why?
|
Histocytochemistry | 1 | 2011 | 130 | 0.100 |
Why?
|
Glycomics | 1 | 2010 | 1 | 0.100 |
Why?
|
Virus Replication | 4 | 2018 | 319 | 0.100 |
Why?
|
Chromosomes, Human, Pair 18 | 2 | 2008 | 42 | 0.100 |
Why?
|
Kidney Failure, Chronic | 2 | 2008 | 509 | 0.100 |
Why?
|
Calcium | 2 | 2013 | 1156 | 0.100 |
Why?
|
Hematopoiesis | 1 | 2011 | 163 | 0.100 |
Why?
|
Sirtuins | 1 | 2011 | 45 | 0.100 |
Why?
|
Wnt Signaling Pathway | 1 | 2011 | 91 | 0.100 |
Why?
|
Gene Knockout Techniques | 3 | 2017 | 77 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2007 | 189 | 0.100 |
Why?
|
Musculoskeletal System | 1 | 2010 | 14 | 0.100 |
Why?
|
Myosin-Light-Chain Kinase | 1 | 2010 | 41 | 0.100 |
Why?
|
Collagen Type I | 1 | 2011 | 62 | 0.100 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2010 | 57 | 0.100 |
Why?
|
Double-Blind Method | 4 | 2018 | 1823 | 0.100 |
Why?
|
Xedar Receptor | 1 | 2010 | 1 | 0.100 |
Why?
|
Graft Rejection | 1 | 2016 | 1065 | 0.100 |
Why?
|
Ectodysplasins | 1 | 2010 | 5 | 0.100 |
Why?
|
Pregnanediones | 1 | 2010 | 1 | 0.100 |
Why?
|
Community Networks | 1 | 2010 | 29 | 0.100 |
Why?
|
Receptors, CCR6 | 1 | 2010 | 3 | 0.090 |
Why?
|
Tuberculosis | 1 | 2012 | 110 | 0.090 |
Why?
|
Alpha Particles | 2 | 2021 | 4 | 0.090 |
Why?
|
Osteonectin | 1 | 2010 | 22 | 0.090 |
Why?
|
Optic Atrophy, Hereditary, Leber | 1 | 2010 | 2 | 0.090 |
Why?
|
Intra-Abdominal Fat | 1 | 2010 | 29 | 0.090 |
Why?
|
Receptors, Glucocorticoid | 1 | 2011 | 120 | 0.090 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 2 | 2012 | 27 | 0.090 |
Why?
|
Co-Repressor Proteins | 1 | 2010 | 18 | 0.090 |
Why?
|
Metalloproteases | 1 | 2010 | 10 | 0.090 |
Why?
|
E2F2 Transcription Factor | 1 | 2010 | 4 | 0.090 |
Why?
|
Hemoglobin E | 1 | 2010 | 1 | 0.090 |
Why?
|
Oxidoreductases Acting on Sulfur Group Donors | 1 | 2010 | 1 | 0.090 |
Why?
|
Immunization, Passive | 1 | 2010 | 71 | 0.090 |
Why?
|
Liver Cirrhosis | 1 | 2013 | 297 | 0.090 |
Why?
|
Phospholipase C beta | 1 | 2010 | 2 | 0.090 |
Why?
|
Receptor Cross-Talk | 1 | 2010 | 33 | 0.090 |
Why?
|
Lipodystrophy | 1 | 2010 | 3 | 0.090 |
Why?
|
Chromosomes, Human | 3 | 2011 | 66 | 0.090 |
Why?
|
beta-Thalassemia | 1 | 2010 | 6 | 0.090 |
Why?
|
Solitary Nucleus | 1 | 2010 | 21 | 0.090 |
Why?
|
Pressoreceptors | 1 | 2010 | 22 | 0.090 |
Why?
|
Insulin | 2 | 2013 | 1160 | 0.090 |
Why?
|
Alcohol Drinking | 2 | 2011 | 267 | 0.090 |
Why?
|
Eye Proteins | 2 | 2015 | 128 | 0.090 |
Why?
|
Leptin | 1 | 2010 | 105 | 0.090 |
Why?
|
Biometry | 1 | 2010 | 66 | 0.090 |
Why?
|
Aldose-Ketose Isomerases | 1 | 2009 | 2 | 0.090 |
Why?
|
Transcription Factor AP-2 | 2 | 2010 | 14 | 0.090 |
Why?
|
Base Pairing | 1 | 2010 | 55 | 0.090 |
Why?
|
cdc42 GTP-Binding Protein | 2 | 2010 | 11 | 0.090 |
Why?
|
Peripheral Vascular Diseases | 1 | 2010 | 62 | 0.090 |
Why?
|
Psoriasis | 1 | 2013 | 240 | 0.090 |
Why?
|
HMGB1 Protein | 1 | 2009 | 16 | 0.090 |
Why?
|
Anti-Retroviral Agents | 1 | 2010 | 30 | 0.090 |
Why?
|
Cell Communication | 1 | 2011 | 194 | 0.090 |
Why?
|
HLA Antigens | 3 | 2018 | 232 | 0.090 |
Why?
|
Mice, Transgenic | 5 | 2015 | 1540 | 0.090 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2009 | 27 | 0.090 |
Why?
|
Aldosterone | 1 | 2010 | 65 | 0.090 |
Why?
|
Forensic Medicine | 1 | 2009 | 6 | 0.090 |
Why?
|
Wnt Proteins | 5 | 2010 | 123 | 0.090 |
Why?
|
Acetyltransferases | 1 | 2009 | 29 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2011 | 170 | 0.090 |
Why?
|
Maximum Tolerated Dose | 1 | 2010 | 270 | 0.090 |
Why?
|
Interleukin-18 | 1 | 2009 | 26 | 0.090 |
Why?
|
Kidney Tubules, Proximal | 1 | 2010 | 61 | 0.090 |
Why?
|
International Cooperation | 1 | 2010 | 127 | 0.090 |
Why?
|
Home Care Services | 1 | 2010 | 72 | 0.090 |
Why?
|
Interleukin-12 | 2 | 2012 | 108 | 0.090 |
Why?
|
Antibodies, Neutralizing | 1 | 2010 | 112 | 0.090 |
Why?
|
Leukocytes, Mononuclear | 2 | 2021 | 196 | 0.090 |
Why?
|
Protein Conformation | 2 | 2021 | 881 | 0.090 |
Why?
|
Hypertension | 2 | 2009 | 1141 | 0.090 |
Why?
|
Genes | 1 | 2010 | 305 | 0.090 |
Why?
|
Imatinib Mesylate | 3 | 2007 | 126 | 0.090 |
Why?
|
Centromere | 1 | 2009 | 26 | 0.090 |
Why?
|
Polymorphism, Restriction Fragment Length | 5 | 2005 | 147 | 0.090 |
Why?
|
Hydro-Lyases | 1 | 2009 | 6 | 0.090 |
Why?
|
Immunity, Innate | 2 | 2013 | 409 | 0.090 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 151 | 0.090 |
Why?
|
Anaphylaxis | 1 | 2009 | 33 | 0.090 |
Why?
|
Group II Chaperonins | 1 | 2009 | 1 | 0.090 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2010 | 114 | 0.090 |
Why?
|
Adenoviridae | 6 | 2008 | 345 | 0.090 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 2009 | 23 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 2 | 2014 | 316 | 0.090 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 25 | 0.090 |
Why?
|
Extracellular Matrix | 1 | 2011 | 232 | 0.090 |
Why?
|
Semaphorins | 2 | 2006 | 17 | 0.090 |
Why?
|
Castration | 1 | 2009 | 41 | 0.090 |
Why?
|
Rhinitis, Allergic, Perennial | 1 | 2009 | 81 | 0.090 |
Why?
|
Selection, Genetic | 3 | 2007 | 502 | 0.090 |
Why?
|
Integrins | 1 | 2009 | 76 | 0.090 |
Why?
|
Glucocorticoids | 1 | 2011 | 352 | 0.090 |
Why?
|
Body Fat Distribution | 1 | 2009 | 13 | 0.090 |
Why?
|
Biomedical Research | 1 | 2013 | 376 | 0.090 |
Why?
|
Patents as Topic | 1 | 2009 | 12 | 0.090 |
Why?
|
Premenopause | 1 | 2009 | 54 | 0.090 |
Why?
|
Sendai virus | 1 | 2008 | 8 | 0.080 |
Why?
|
Fatty Acids | 1 | 2009 | 130 | 0.080 |
Why?
|
Comorbidity | 3 | 2017 | 943 | 0.080 |
Why?
|
Eukaryotic Cells | 1 | 2009 | 43 | 0.080 |
Why?
|
Cross-Sectional Studies | 4 | 2017 | 1621 | 0.080 |
Why?
|
Osteonecrosis | 1 | 2008 | 21 | 0.080 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 364 | 0.080 |
Why?
|
Muscle, Smooth, Vascular | 3 | 2009 | 231 | 0.080 |
Why?
|
Androstadienes | 3 | 2014 | 72 | 0.080 |
Why?
|
STAT4 Transcription Factor | 1 | 2008 | 10 | 0.080 |
Why?
|
Schizosaccharomyces | 1 | 2009 | 54 | 0.080 |
Why?
|
Benzamides | 3 | 2007 | 229 | 0.080 |
Why?
|
Food Hypersensitivity | 1 | 2009 | 63 | 0.080 |
Why?
|
Recombination, Genetic | 2 | 2007 | 439 | 0.080 |
Why?
|
Palliative Care | 1 | 2010 | 257 | 0.080 |
Why?
|
Rhinitis, Allergic, Seasonal | 1 | 2009 | 179 | 0.080 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2008 | 70 | 0.080 |
Why?
|
Neurons | 3 | 2015 | 1546 | 0.080 |
Why?
|
Receptors, Dopamine D2 | 1 | 2009 | 57 | 0.080 |
Why?
|
Kidney Diseases, Cystic | 1 | 2008 | 23 | 0.080 |
Why?
|
Precancerous Conditions | 1 | 2010 | 196 | 0.080 |
Why?
|
Toll-Like Receptors | 2 | 2006 | 92 | 0.080 |
Why?
|
Rhabdomyolysis | 1 | 2008 | 28 | 0.080 |
Why?
|
RGS Proteins | 1 | 2008 | 19 | 0.080 |
Why?
|
Intraoperative Care | 2 | 2019 | 82 | 0.080 |
Why?
|
Neutrophils | 1 | 2010 | 307 | 0.080 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2008 | 14 | 0.080 |
Why?
|
Chondrogenesis | 2 | 2005 | 26 | 0.080 |
Why?
|
Solute Carrier Organic Anion Transporter Family Member 1B3 | 1 | 2008 | 4 | 0.080 |
Why?
|
Anxiety | 1 | 2010 | 287 | 0.080 |
Why?
|
Parkinson Disease | 1 | 2009 | 132 | 0.080 |
Why?
|
Alternative Splicing | 5 | 2008 | 201 | 0.080 |
Why?
|
Chondrocytes | 2 | 2010 | 60 | 0.080 |
Why?
|
Atrial Fibrillation | 1 | 2012 | 288 | 0.080 |
Why?
|
Oxidative Stress | 3 | 2012 | 447 | 0.080 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2007 | 5 | 0.080 |
Why?
|
Patient Care Team | 1 | 2010 | 280 | 0.080 |
Why?
|
Inositol 1,4,5-Trisphosphate Receptors | 1 | 2008 | 17 | 0.080 |
Why?
|
Nerve Growth Factors | 2 | 2005 | 63 | 0.080 |
Why?
|
Syndrome | 1 | 2009 | 446 | 0.080 |
Why?
|
GABA Agents | 1 | 2007 | 8 | 0.080 |
Why?
|
Coronary Aneurysm | 1 | 2007 | 16 | 0.080 |
Why?
|
Republic of Korea | 3 | 2014 | 31 | 0.080 |
Why?
|
Lung Diseases, Interstitial | 1 | 2011 | 235 | 0.080 |
Why?
|
Tubulin | 2 | 2005 | 58 | 0.080 |
Why?
|
G2 Phase | 1 | 2007 | 34 | 0.080 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2007 | 6 | 0.080 |
Why?
|
Activating Transcription Factor 6 | 1 | 2007 | 5 | 0.080 |
Why?
|
Receptors, GABA-A | 1 | 2007 | 32 | 0.080 |
Why?
|
Nitrobenzenes | 1 | 2007 | 11 | 0.080 |
Why?
|
Neurocalcin | 1 | 2007 | 2 | 0.080 |
Why?
|
Receptor, Angiotensin, Type 1 | 2 | 2006 | 21 | 0.080 |
Why?
|
National Health Programs | 1 | 2007 | 20 | 0.080 |
Why?
|
Precipitin Tests | 2 | 2004 | 108 | 0.080 |
Why?
|
Angiogenic Proteins | 1 | 2007 | 17 | 0.080 |
Why?
|
Laminin | 2 | 2004 | 85 | 0.080 |
Why?
|
Proteoglycans | 2 | 2005 | 121 | 0.080 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2007 | 80 | 0.080 |
Why?
|
Behavior, Animal | 1 | 2010 | 373 | 0.080 |
Why?
|
Reperfusion Injury | 1 | 2008 | 131 | 0.080 |
Why?
|
Symporters | 2 | 2008 | 107 | 0.080 |
Why?
|
Receptors, Interleukin | 1 | 2007 | 35 | 0.080 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2007 | 83 | 0.080 |
Why?
|
Mitochondrial Diseases | 1 | 2007 | 10 | 0.080 |
Why?
|
Inflammation | 2 | 2010 | 920 | 0.080 |
Why?
|
Alpha-Globulins | 1 | 2007 | 11 | 0.080 |
Why?
|
Survivors | 1 | 2009 | 226 | 0.080 |
Why?
|
Chromogranins | 1 | 2007 | 11 | 0.080 |
Why?
|
Multicenter Studies as Topic | 1 | 2007 | 159 | 0.080 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 151 | 0.070 |
Why?
|
Gene Duplication | 1 | 2008 | 125 | 0.070 |
Why?
|
Autoimmunity | 2 | 2005 | 160 | 0.070 |
Why?
|
Opisthorchis | 1 | 2006 | 1 | 0.070 |
Why?
|
Brain Infarction | 1 | 2007 | 22 | 0.070 |
Why?
|
Receptors, Neurotensin | 1 | 2006 | 3 | 0.070 |
Why?
|
Spectrometry, Fluorescence | 1 | 2007 | 85 | 0.070 |
Why?
|
Toxoplasma | 1 | 2007 | 108 | 0.070 |
Why?
|
Genome, Viral | 2 | 2020 | 74 | 0.070 |
Why?
|
Chronic Disease | 2 | 2023 | 971 | 0.070 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2006 | 10 | 0.070 |
Why?
|
Chemokine CCL5 | 1 | 2006 | 16 | 0.070 |
Why?
|
Asia | 3 | 2012 | 95 | 0.070 |
Why?
|
Biopsy, Needle | 3 | 2018 | 235 | 0.070 |
Why?
|
Secretory Vesicles | 1 | 2007 | 43 | 0.070 |
Why?
|
CDC2 Protein Kinase | 3 | 2014 | 45 | 0.070 |
Why?
|
DNA, Mitochondrial | 1 | 2007 | 183 | 0.070 |
Why?
|
Chemokines, CC | 1 | 2006 | 34 | 0.070 |
Why?
|
Multienzyme Complexes | 1 | 2006 | 64 | 0.070 |
Why?
|
Cerebral Infarction | 1 | 2007 | 71 | 0.070 |
Why?
|
Chemistry, Physical | 1 | 2006 | 29 | 0.070 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2006 | 1 | 0.070 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2007 | 126 | 0.070 |
Why?
|
B-Lymphocytes | 4 | 2021 | 724 | 0.070 |
Why?
|
Sp1 Transcription Factor | 3 | 2013 | 19 | 0.070 |
Why?
|
Cerumen | 1 | 2006 | 3 | 0.070 |
Why?
|
Silicon | 1 | 2006 | 18 | 0.070 |
Why?
|
Cytochrome c Group | 2 | 2003 | 82 | 0.070 |
Why?
|
Peptidylprolyl Isomerase | 1 | 2006 | 8 | 0.070 |
Why?
|
Hypersensitivity | 1 | 2007 | 154 | 0.070 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2005 | 222 | 0.070 |
Why?
|
EGF Family of Proteins | 1 | 2005 | 4 | 0.070 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2006 | 78 | 0.070 |
Why?
|
Amphiregulin | 1 | 2005 | 7 | 0.070 |
Why?
|
Transplantation, Heterologous | 2 | 2007 | 363 | 0.070 |
Why?
|
Adoptive Transfer | 2 | 2021 | 168 | 0.070 |
Why?
|
Hypersensitivity, Immediate | 1 | 2006 | 62 | 0.070 |
Why?
|
Plakophilins | 1 | 2005 | 4 | 0.070 |
Why?
|
Esophagus | 1 | 2006 | 102 | 0.070 |
Why?
|
Ultraviolet Rays | 5 | 2006 | 193 | 0.070 |
Why?
|
Renin-Angiotensin System | 1 | 2006 | 133 | 0.070 |
Why?
|
Feasibility Studies | 3 | 2018 | 751 | 0.070 |
Why?
|
Biopolymers | 1 | 2005 | 26 | 0.070 |
Why?
|
Histone Chaperones | 1 | 2005 | 2 | 0.070 |
Why?
|
Confidentiality | 1 | 2005 | 78 | 0.070 |
Why?
|
Amino Acyl-tRNA Synthetases | 1 | 2005 | 14 | 0.070 |
Why?
|
Analysis of Variance | 3 | 2012 | 912 | 0.070 |
Why?
|
Pattern Recognition, Automated | 1 | 2007 | 217 | 0.070 |
Why?
|
Laser Capture Microdissection | 2 | 2017 | 20 | 0.070 |
Why?
|
Chaperonins | 1 | 2005 | 10 | 0.070 |
Why?
|
Catenins | 1 | 2005 | 11 | 0.070 |
Why?
|
Intervertebral Disc Displacement | 1 | 2005 | 24 | 0.070 |
Why?
|
Apoptotic Protease-Activating Factor 1 | 1 | 2005 | 7 | 0.070 |
Why?
|
Diabetes Complications | 2 | 2017 | 207 | 0.070 |
Why?
|
Urea | 1 | 2005 | 57 | 0.070 |
Why?
|
Hyperphagia | 1 | 2005 | 35 | 0.070 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2005 | 48 | 0.070 |
Why?
|
Calcineurin Inhibitors | 1 | 2005 | 54 | 0.070 |
Why?
|
Immunophenotyping | 2 | 2018 | 211 | 0.070 |
Why?
|
Caspase 9 | 1 | 2005 | 48 | 0.070 |
Why?
|
Caspase Inhibitors | 1 | 2005 | 33 | 0.070 |
Why?
|
Serology | 1 | 2004 | 3 | 0.070 |
Why?
|
Leucine | 2 | 2020 | 67 | 0.070 |
Why?
|
ADAM Proteins | 1 | 2004 | 11 | 0.070 |
Why?
|
GTP Phosphohydrolases | 1 | 2005 | 71 | 0.060 |
Why?
|
Dynamins | 1 | 2005 | 49 | 0.060 |
Why?
|
Thromboembolism | 1 | 2006 | 119 | 0.060 |
Why?
|
Biopsy | 1 | 2009 | 1163 | 0.060 |
Why?
|
Carcinoembryonic Antigen | 1 | 2004 | 41 | 0.060 |
Why?
|
Area Under Curve | 3 | 2011 | 334 | 0.060 |
Why?
|
Citrulline | 3 | 2012 | 10 | 0.060 |
Why?
|
Metabolomics | 2 | 2018 | 68 | 0.060 |
Why?
|
Myocytes, Smooth Muscle | 3 | 2012 | 132 | 0.060 |
Why?
|
E2F Transcription Factors | 1 | 2004 | 19 | 0.060 |
Why?
|
Histone Deacetylase 1 | 1 | 2004 | 13 | 0.060 |
Why?
|
Empyema, Pleural | 1 | 2004 | 9 | 0.060 |
Why?
|
Microdissection | 1 | 2004 | 18 | 0.060 |
Why?
|
Pancreatitis-Associated Proteins | 3 | 2009 | 15 | 0.060 |
Why?
|
Cell Adhesion | 1 | 2006 | 420 | 0.060 |
Why?
|
Carcinoma, Large Cell | 1 | 2004 | 39 | 0.060 |
Why?
|
Consensus Sequence | 3 | 2016 | 64 | 0.060 |
Why?
|
CD40 Ligand | 1 | 2004 | 69 | 0.060 |
Why?
|
Culture Media | 1 | 2004 | 147 | 0.060 |
Why?
|
Immunoglobulin Class Switching | 1 | 2004 | 37 | 0.060 |
Why?
|
Cyclosporine | 1 | 2005 | 234 | 0.060 |
Why?
|
Galectin 2 | 1 | 2004 | 2 | 0.060 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2004 | 40 | 0.060 |
Why?
|
Marfan Syndrome | 1 | 2004 | 28 | 0.060 |
Why?
|
Statistics, Nonparametric | 3 | 2013 | 307 | 0.060 |
Why?
|
Microtubule-Associated Proteins | 1 | 2005 | 176 | 0.060 |
Why?
|
Pancreatic Ducts | 1 | 2004 | 26 | 0.060 |
Why?
|
Lupus Nephritis | 1 | 2005 | 78 | 0.060 |
Why?
|
RNA Polymerase II | 1 | 2004 | 55 | 0.060 |
Why?
|
Molecular Chaperones | 1 | 2004 | 111 | 0.060 |
Why?
|
Ifosfamide | 1 | 2004 | 49 | 0.060 |
Why?
|
DNA Breaks, Double-Stranded | 2 | 2014 | 64 | 0.060 |
Why?
|
Lumbar Vertebrae | 1 | 2005 | 148 | 0.060 |
Why?
|
Chromosomes, Human, X | 1 | 2004 | 55 | 0.060 |
Why?
|
Small Molecule Libraries | 2 | 2016 | 61 | 0.060 |
Why?
|
Databases as Topic | 1 | 2004 | 92 | 0.060 |
Why?
|
Receptors, Interleukin-4 | 1 | 2003 | 9 | 0.060 |
Why?
|
Alcohol Oxidoreductases | 1 | 2003 | 17 | 0.060 |
Why?
|
Microscopy, Fluorescence | 4 | 2007 | 425 | 0.060 |
Why?
|
Hyaluronoglucosaminidase | 1 | 2003 | 10 | 0.060 |
Why?
|
NIMA-Related Kinases | 2 | 2014 | 7 | 0.060 |
Why?
|
Organ of Corti | 1 | 2003 | 10 | 0.060 |
Why?
|
Transcription Factor 4 | 1 | 2003 | 4 | 0.060 |
Why?
|
Tacrolimus | 1 | 2005 | 373 | 0.060 |
Why?
|
Carcinoma, Endometrioid | 1 | 2004 | 43 | 0.060 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 2 | 2019 | 52 | 0.060 |
Why?
|
Receptors, Vasopressin | 1 | 2003 | 7 | 0.060 |
Why?
|
Electron Transport Complex IV | 1 | 2003 | 47 | 0.060 |
Why?
|
Receptors, Prostaglandin | 1 | 2003 | 7 | 0.060 |
Why?
|
T-Box Domain Proteins | 1 | 2005 | 118 | 0.060 |
Why?
|
Hyperthermia, Induced | 1 | 2004 | 73 | 0.060 |
Why?
|
Receptor, Angiotensin, Type 2 | 1 | 2003 | 6 | 0.060 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2003 | 4 | 0.060 |
Why?
|
Deoxyribonucleotides | 1 | 2003 | 8 | 0.060 |
Why?
|
Receptors, Dopamine | 1 | 2003 | 38 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2013 | 865 | 0.060 |
Why?
|
Conserved Sequence | 1 | 2004 | 210 | 0.060 |
Why?
|
Esters | 1 | 2023 | 29 | 0.060 |
Why?
|
Heparan Sulfate Proteoglycans | 1 | 2003 | 21 | 0.060 |
Why?
|
Oligodeoxyribonucleotides, Antisense | 1 | 2003 | 16 | 0.060 |
Why?
|
Cysteine Endopeptidases | 1 | 2003 | 87 | 0.060 |
Why?
|
Darbepoetin alfa | 1 | 2023 | 5 | 0.060 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2003 | 54 | 0.060 |
Why?
|
Transcriptional Regulator ERG | 1 | 2003 | 15 | 0.060 |
Why?
|
F-Box Proteins | 1 | 2003 | 8 | 0.060 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2003 | 12 | 0.060 |
Why?
|
Wound Healing | 1 | 2005 | 344 | 0.060 |
Why?
|
Blast Crisis | 1 | 2003 | 33 | 0.060 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2018 | 213 | 0.060 |
Why?
|
Cyclin E | 1 | 2003 | 27 | 0.060 |
Why?
|
Scleroproteins | 1 | 2003 | 1 | 0.060 |
Why?
|
Biotransformation | 2 | 2014 | 50 | 0.060 |
Why?
|
Muscular Dystrophies | 1 | 2003 | 54 | 0.060 |
Why?
|
Herpes Simplex | 1 | 2004 | 202 | 0.060 |
Why?
|
Bacteriophage T7 | 1 | 2003 | 7 | 0.060 |
Why?
|
Quality Control | 2 | 2014 | 117 | 0.060 |
Why?
|
Informed Consent | 1 | 2005 | 266 | 0.060 |
Why?
|
Lymphocyte Depletion | 1 | 2003 | 97 | 0.060 |
Why?
|
Gene-Environment Interaction | 2 | 2014 | 103 | 0.060 |
Why?
|
Postural Balance | 1 | 2003 | 42 | 0.060 |
Why?
|
ATP Binding Cassette Transporter 1 | 1 | 2002 | 9 | 0.060 |
Why?
|
Menstrual Cycle | 1 | 2003 | 55 | 0.060 |
Why?
|
Lymphoma | 1 | 2004 | 262 | 0.060 |
Why?
|
Bone Density | 2 | 2014 | 209 | 0.060 |
Why?
|
Femoral Artery | 1 | 2003 | 81 | 0.060 |
Why?
|
Tunica Intima | 1 | 2003 | 59 | 0.060 |
Why?
|
Chromosome Breakage | 1 | 2002 | 17 | 0.060 |
Why?
|
Eye | 1 | 2003 | 111 | 0.060 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2003 | 69 | 0.060 |
Why?
|
NADP | 1 | 2002 | 45 | 0.050 |
Why?
|
Chromosomes, Human, Pair 16 | 2 | 2013 | 79 | 0.050 |
Why?
|
Chromosome Inversion | 1 | 2002 | 47 | 0.050 |
Why?
|
Carbocyanines | 1 | 2002 | 18 | 0.050 |
Why?
|
Hearing | 1 | 2003 | 59 | 0.050 |
Why?
|
Biomarkers, Pharmacological | 2 | 2012 | 22 | 0.050 |
Why?
|
Glutathione Transferase | 1 | 2002 | 111 | 0.050 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2002 | 30 | 0.050 |
Why?
|
Death, Sudden, Cardiac | 1 | 2002 | 45 | 0.050 |
Why?
|
Glomerulonephritis | 1 | 2003 | 75 | 0.050 |
Why?
|
Ossification of Posterior Longitudinal Ligament | 1 | 2002 | 1 | 0.050 |
Why?
|
Genes, MDR | 1 | 2002 | 7 | 0.050 |
Why?
|
Glycerophosphates | 1 | 2002 | 5 | 0.050 |
Why?
|
HLA-DR alpha-Chains | 1 | 2002 | 4 | 0.050 |
Why?
|
CHO Cells | 3 | 2008 | 187 | 0.050 |
Why?
|
Bone Diseases, Metabolic | 1 | 2002 | 33 | 0.050 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2022 | 28 | 0.050 |
Why?
|
Epoprostenol | 1 | 2022 | 46 | 0.050 |
Why?
|
Trinucleotide Repeats | 1 | 2002 | 31 | 0.050 |
Why?
|
Golgi Apparatus | 2 | 2017 | 117 | 0.050 |
Why?
|
Mass Screening | 2 | 2021 | 618 | 0.050 |
Why?
|
Constriction, Pathologic | 1 | 2003 | 213 | 0.050 |
Why?
|
Osteoblasts | 1 | 2002 | 95 | 0.050 |
Why?
|
Carboxylic Ester Hydrolases | 1 | 2002 | 23 | 0.050 |
Why?
|
DNA Helicases | 1 | 2002 | 79 | 0.050 |
Why?
|
Familial Primary Pulmonary Hypertension | 1 | 2022 | 60 | 0.050 |
Why?
|
RNA Splicing | 2 | 2017 | 142 | 0.050 |
Why?
|
Salivary Ducts | 1 | 2021 | 3 | 0.050 |
Why?
|
X Chromosome | 1 | 2002 | 152 | 0.050 |
Why?
|
Singapore | 2 | 2014 | 16 | 0.050 |
Why?
|
Long QT Syndrome | 1 | 2002 | 34 | 0.050 |
Why?
|
Platelet Count | 2 | 2011 | 92 | 0.050 |
Why?
|
Protein Biosynthesis | 3 | 2012 | 378 | 0.050 |
Why?
|
Genetic Pleiotropy | 1 | 2021 | 24 | 0.050 |
Why?
|
Epithelium | 3 | 2008 | 319 | 0.050 |
Why?
|
Lymphoma, B-Cell | 1 | 2002 | 103 | 0.050 |
Why?
|
ras Proteins | 1 | 2002 | 128 | 0.050 |
Why?
|
Cricetinae | 3 | 2008 | 560 | 0.050 |
Why?
|
Bayes Theorem | 2 | 2014 | 361 | 0.050 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2024 | 229 | 0.050 |
Why?
|
Neurodegenerative Diseases | 1 | 2002 | 44 | 0.050 |
Why?
|
Forecasting | 1 | 2002 | 304 | 0.050 |
Why?
|
Endoplasmic Reticulum | 2 | 2017 | 250 | 0.050 |
Why?
|
Freund's Adjuvant | 2 | 2012 | 26 | 0.050 |
Why?
|
Intellectual Disability | 1 | 2002 | 186 | 0.050 |
Why?
|
Fetus | 1 | 2002 | 226 | 0.050 |
Why?
|
Whole Genome Sequencing | 1 | 2021 | 76 | 0.050 |
Why?
|
Age Distribution | 2 | 2012 | 204 | 0.050 |
Why?
|
Immunocompetence | 1 | 2020 | 27 | 0.050 |
Why?
|
Spinocerebellar Ataxias | 1 | 2002 | 73 | 0.050 |
Why?
|
Human papillomavirus 16 | 1 | 2020 | 38 | 0.050 |
Why?
|
HLA-DP alpha-Chains | 2 | 2011 | 6 | 0.050 |
Why?
|
Radiotherapy Dosage | 1 | 2021 | 468 | 0.050 |
Why?
|
HLA-DP beta-Chains | 2 | 2011 | 8 | 0.050 |
Why?
|
Genes, BRCA1 | 1 | 2002 | 192 | 0.050 |
Why?
|
Germ Cells | 1 | 2021 | 126 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2011 | 2232 | 0.050 |
Why?
|
tRNA Methyltransferases | 2 | 2012 | 12 | 0.050 |
Why?
|
Spatio-Temporal Analysis | 1 | 2020 | 21 | 0.050 |
Why?
|
Inheritance Patterns | 1 | 2020 | 48 | 0.050 |
Why?
|
Dexamethasone | 1 | 2002 | 326 | 0.050 |
Why?
|
Ion Channels | 1 | 2002 | 246 | 0.050 |
Why?
|
Gene Amplification | 2 | 2011 | 131 | 0.050 |
Why?
|
Drug Design | 2 | 2012 | 124 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 2003 | 449 | 0.050 |
Why?
|
Fetal Proteins | 1 | 2019 | 17 | 0.050 |
Why?
|
Waist-Hip Ratio | 2 | 2010 | 18 | 0.050 |
Why?
|
Chimerism | 1 | 2020 | 37 | 0.050 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2019 | 29 | 0.050 |
Why?
|
Tumor Protein p73 | 3 | 2005 | 6 | 0.050 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2010 | 75 | 0.050 |
Why?
|
Korea | 2 | 2010 | 17 | 0.040 |
Why?
|
Epigenomics | 1 | 2020 | 100 | 0.040 |
Why?
|
Brain Chemistry | 1 | 2020 | 121 | 0.040 |
Why?
|
Orchiectomy | 2 | 2010 | 68 | 0.040 |
Why?
|
Primary Cell Culture | 1 | 2019 | 72 | 0.040 |
Why?
|
Genes, Dominant | 2 | 2014 | 117 | 0.040 |
Why?
|
Patient Satisfaction | 1 | 2023 | 455 | 0.040 |
Why?
|
DNA Fingerprinting | 2 | 2009 | 16 | 0.040 |
Why?
|
Hematologic Neoplasms | 1 | 2003 | 329 | 0.040 |
Why?
|
Biological Transport | 2 | 2011 | 396 | 0.040 |
Why?
|
Immunoblotting | 3 | 2005 | 268 | 0.040 |
Why?
|
Age of Onset | 2 | 2015 | 310 | 0.040 |
Why?
|
Cell Cycle Checkpoints | 1 | 2019 | 63 | 0.040 |
Why?
|
Containment of Biohazards | 1 | 2019 | 8 | 0.040 |
Why?
|
Recurrence | 2 | 2016 | 1139 | 0.040 |
Why?
|
Intestines | 1 | 2002 | 411 | 0.040 |
Why?
|
Intermediate Filament Proteins | 2 | 2013 | 35 | 0.040 |
Why?
|
Hydrogen Peroxide | 2 | 2014 | 158 | 0.040 |
Why?
|
Drug Synergism | 1 | 2019 | 303 | 0.040 |
Why?
|
Biological Evolution | 1 | 2006 | 919 | 0.040 |
Why?
|
Cell-Free Nucleic Acids | 1 | 2020 | 71 | 0.040 |
Why?
|
Frozen Sections | 1 | 2019 | 48 | 0.040 |
Why?
|
Cyclin B1 | 2 | 2009 | 17 | 0.040 |
Why?
|
Antiporters | 2 | 2009 | 18 | 0.040 |
Why?
|
Mutation, Missense | 2 | 2011 | 276 | 0.040 |
Why?
|
Global Health | 1 | 2020 | 193 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2020 | 493 | 0.040 |
Why?
|
Heart | 1 | 2002 | 539 | 0.040 |
Why?
|
Enzyme Stability | 1 | 2018 | 39 | 0.040 |
Why?
|
Equipment Design | 1 | 2020 | 406 | 0.040 |
Why?
|
Computer Simulation | 3 | 2008 | 1078 | 0.040 |
Why?
|
Heterografts | 1 | 2019 | 98 | 0.040 |
Why?
|
Genes, Neoplasm | 2 | 2010 | 37 | 0.040 |
Why?
|
Specimen Handling | 1 | 2019 | 98 | 0.040 |
Why?
|
Poly I-C | 2 | 2008 | 16 | 0.040 |
Why?
|
Citrullination | 1 | 2018 | 1 | 0.040 |
Why?
|
TATA-Binding Protein Associated Factors | 1 | 2018 | 3 | 0.040 |
Why?
|
Necrosis | 1 | 2018 | 204 | 0.040 |
Why?
|
RNA-Binding Protein FUS | 1 | 2018 | 11 | 0.040 |
Why?
|
Protein Aggregates | 1 | 2018 | 20 | 0.040 |
Why?
|
Immunization | 1 | 2018 | 158 | 0.040 |
Why?
|
Pilot Projects | 1 | 2020 | 839 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2018 | 116 | 0.040 |
Why?
|
Cysteine | 1 | 2018 | 135 | 0.040 |
Why?
|
Genetic Engineering | 1 | 2018 | 114 | 0.040 |
Why?
|
United States | 1 | 2010 | 6672 | 0.040 |
Why?
|
Transplantation Conditioning | 1 | 2020 | 373 | 0.040 |
Why?
|
Photic Stimulation | 1 | 2020 | 493 | 0.040 |
Why?
|
Antihypertensive Agents | 1 | 2022 | 521 | 0.040 |
Why?
|
Hepatitis A Virus Cellular Receptor 2 | 1 | 2017 | 5 | 0.040 |
Why?
|
Transplantation, Homologous | 1 | 2020 | 996 | 0.040 |
Why?
|
Cricetulus | 2 | 2008 | 126 | 0.040 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2017 | 33 | 0.040 |
Why?
|
Genetic Research | 1 | 2017 | 17 | 0.040 |
Why?
|
Pancreatectomy | 2 | 2009 | 148 | 0.040 |
Why?
|
Chromosome Breakpoints | 1 | 2016 | 15 | 0.040 |
Why?
|
Fallopian Tubes | 1 | 2017 | 41 | 0.040 |
Why?
|
Hypothalamus | 2 | 2007 | 79 | 0.040 |
Why?
|
Immunoglobulin E | 2 | 2009 | 144 | 0.040 |
Why?
|
Perforin | 1 | 2016 | 55 | 0.040 |
Why?
|
CD4 Antigens | 1 | 2016 | 83 | 0.040 |
Why?
|
Visual Cortex | 1 | 2020 | 251 | 0.040 |
Why?
|
Medical History Taking | 1 | 2017 | 80 | 0.040 |
Why?
|
Chemoprevention | 1 | 2017 | 91 | 0.040 |
Why?
|
Prevalence | 2 | 2012 | 1239 | 0.040 |
Why?
|
Linear Models | 1 | 2018 | 421 | 0.040 |
Why?
|
Tyrosine | 1 | 2016 | 133 | 0.040 |
Why?
|
Cytotoxicity Tests, Immunologic | 2 | 2007 | 44 | 0.040 |
Why?
|
Mucin-4 | 1 | 2016 | 7 | 0.040 |
Why?
|
Telomere | 1 | 2017 | 108 | 0.040 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2016 | 107 | 0.040 |
Why?
|
Lod Score | 2 | 2007 | 152 | 0.040 |
Why?
|
Iron Regulatory Protein 1 | 1 | 2015 | 1 | 0.030 |
Why?
|
Bystander Effect | 1 | 2015 | 12 | 0.030 |
Why?
|
RNA Isoforms | 1 | 2015 | 5 | 0.030 |
Why?
|
Health Surveys | 1 | 2017 | 239 | 0.030 |
Why?
|
Vitamin D | 1 | 2018 | 261 | 0.030 |
Why?
|
Intracellular Space | 1 | 2015 | 38 | 0.030 |
Why?
|
Threonine | 1 | 2015 | 33 | 0.030 |
Why?
|
Ferritins | 1 | 2015 | 29 | 0.030 |
Why?
|
Cross-Priming | 1 | 2015 | 48 | 0.030 |
Why?
|
Ileum | 1 | 2016 | 159 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcr | 1 | 2015 | 7 | 0.030 |
Why?
|
Programmed Cell Death 1 Receptor | 1 | 2017 | 159 | 0.030 |
Why?
|
Prednisone | 1 | 2016 | 258 | 0.030 |
Why?
|
Pharmacogenomic Testing | 1 | 2016 | 97 | 0.030 |
Why?
|
Dimerization | 2 | 2006 | 143 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 217 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2014 | 40 | 0.030 |
Why?
|
DNA Modification Methylases | 1 | 2014 | 25 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 2014 | 78 | 0.030 |
Why?
|
Formaldehyde | 1 | 2014 | 52 | 0.030 |
Why?
|
Mediastinum | 1 | 2014 | 46 | 0.030 |
Why?
|
Interleukin-4 | 2 | 2006 | 127 | 0.030 |
Why?
|
Toremifene | 1 | 2014 | 1 | 0.030 |
Why?
|
Mouth Mucosa | 1 | 2014 | 67 | 0.030 |
Why?
|
Poly Adenosine Diphosphate Ribose | 1 | 2014 | 4 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 1 | 2017 | 311 | 0.030 |
Why?
|
In Vitro Techniques | 2 | 2007 | 989 | 0.030 |
Why?
|
Enzyme Activators | 1 | 2014 | 14 | 0.030 |
Why?
|
Probability | 2 | 2008 | 355 | 0.030 |
Why?
|
Cell Separation | 1 | 2014 | 196 | 0.030 |
Why?
|
RNA Splicing Factors | 1 | 2014 | 27 | 0.030 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2014 | 42 | 0.030 |
Why?
|
Biopsy, Fine-Needle | 1 | 2014 | 93 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2016 | 319 | 0.030 |
Why?
|
Pandemics | 1 | 2020 | 740 | 0.030 |
Why?
|
Organoplatinum Compounds | 1 | 2014 | 94 | 0.030 |
Why?
|
Positron Emission Tomography Computed Tomography | 1 | 2014 | 86 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2012 | 2379 | 0.030 |
Why?
|
Dissection | 2 | 2005 | 42 | 0.030 |
Why?
|
Protein Kinase C-theta | 1 | 2013 | 16 | 0.030 |
Why?
|
Drosophila Proteins | 2 | 2011 | 488 | 0.030 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2015 | 104 | 0.030 |
Why?
|
Celecoxib | 1 | 2013 | 31 | 0.030 |
Why?
|
Colony-Forming Units Assay | 2 | 2004 | 40 | 0.030 |
Why?
|
Reference Standards | 1 | 2014 | 159 | 0.030 |
Why?
|
Estrogen Receptor Modulators | 1 | 2013 | 10 | 0.030 |
Why?
|
Benzoates | 1 | 2013 | 44 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 95 | 0.030 |
Why?
|
Molecular Weight | 1 | 2013 | 332 | 0.030 |
Why?
|
Germany | 1 | 2013 | 72 | 0.030 |
Why?
|
Receptors, Histamine H1 | 1 | 2013 | 8 | 0.030 |
Why?
|
Spectrin | 1 | 2013 | 15 | 0.030 |
Why?
|
Amino Acids | 1 | 2014 | 252 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2013 | 188 | 0.030 |
Why?
|
Kupffer Cells | 1 | 2013 | 13 | 0.030 |
Why?
|
HLA-DQ alpha-Chains | 1 | 2013 | 16 | 0.030 |
Why?
|
Research Design | 1 | 2017 | 594 | 0.030 |
Why?
|
Plicamycin | 1 | 2013 | 9 | 0.030 |
Why?
|
S Phase | 1 | 2013 | 62 | 0.030 |
Why?
|
G1 Phase | 1 | 2013 | 63 | 0.030 |
Why?
|
Regulatory Factor X Transcription Factors | 1 | 2012 | 11 | 0.030 |
Why?
|
Receptor, Insulin | 1 | 2013 | 54 | 0.030 |
Why?
|
Nucleotide Motifs | 1 | 2013 | 47 | 0.030 |
Why?
|
Wnt4 Protein | 1 | 2012 | 3 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2014 | 176 | 0.030 |
Why?
|
Inhibins | 1 | 2012 | 37 | 0.030 |
Why?
|
Cyclin G1 | 1 | 2012 | 2 | 0.030 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2014 | 155 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2012 | 64 | 0.030 |
Why?
|
Cytochrome P-450 CYP2A6 | 1 | 2012 | 9 | 0.030 |
Why?
|
Glycopeptides | 1 | 2012 | 16 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 1565 | 0.030 |
Why?
|
src Homology Domains | 1 | 2012 | 44 | 0.030 |
Why?
|
Cell Nucleolus | 1 | 2012 | 23 | 0.030 |
Why?
|
Receptor, EphA5 | 1 | 2012 | 2 | 0.030 |
Why?
|
Hawaii | 1 | 2012 | 26 | 0.030 |
Why?
|
Trypsin | 1 | 2012 | 95 | 0.030 |
Why?
|
Blood Urea Nitrogen | 1 | 2012 | 34 | 0.030 |
Why?
|
Butyrophilins | 1 | 2012 | 22 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2012 | 244 | 0.030 |
Why?
|
Antigens, Nuclear | 1 | 2012 | 25 | 0.030 |
Why?
|
Sex Distribution | 1 | 2012 | 173 | 0.030 |
Why?
|
Virus Integration | 1 | 2012 | 16 | 0.030 |
Why?
|
Death-Associated Protein Kinases | 1 | 2012 | 6 | 0.030 |
Why?
|
Proteome | 1 | 2013 | 124 | 0.030 |
Why?
|
Receptors, Interleukin-1 Type II | 1 | 2012 | 3 | 0.030 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2013 | 132 | 0.030 |
Why?
|
Receptors, Interleukin-12 | 1 | 2012 | 9 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2012 | 55 | 0.030 |
Why?
|
California | 1 | 2012 | 138 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2013 | 140 | 0.030 |
Why?
|
Fluorouracil | 1 | 2014 | 556 | 0.030 |
Why?
|
Transcriptional Elongation Factors | 1 | 2012 | 23 | 0.030 |
Why?
|
HapMap Project | 1 | 2012 | 47 | 0.030 |
Why?
|
Taiwan | 1 | 2012 | 23 | 0.030 |
Why?
|
ORAI1 Protein | 1 | 2012 | 10 | 0.030 |
Why?
|
Ribosomes | 1 | 2012 | 111 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2013 | 187 | 0.030 |
Why?
|
G1 Phase Cell Cycle Checkpoints | 1 | 2011 | 3 | 0.030 |
Why?
|
Erythrocyte Count | 1 | 2011 | 23 | 0.030 |
Why?
|
Lamin Type A | 1 | 2012 | 24 | 0.030 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2011 | 26 | 0.030 |
Why?
|
Normal Distribution | 1 | 2011 | 37 | 0.030 |
Why?
|
Students | 1 | 2013 | 147 | 0.030 |
Why?
|
SEER Program | 1 | 2012 | 190 | 0.030 |
Why?
|
Cell Size | 1 | 2011 | 65 | 0.030 |
Why?
|
Thyroidectomy | 1 | 2012 | 170 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2011 | 73 | 0.030 |
Why?
|
Cleavage Stimulation Factor | 1 | 2011 | 1 | 0.030 |
Why?
|
Aspartate Aminotransferases | 1 | 2011 | 73 | 0.030 |
Why?
|
Cyclin D1 | 1 | 2011 | 83 | 0.030 |
Why?
|
Azepines | 1 | 2011 | 20 | 0.030 |
Why?
|
Caprylates | 1 | 2011 | 11 | 0.030 |
Why?
|
Lysophospholipase | 1 | 2011 | 3 | 0.030 |
Why?
|
Protein Interaction Maps | 1 | 2011 | 48 | 0.030 |
Why?
|
Chemokine CXCL2 | 1 | 2011 | 16 | 0.030 |
Why?
|
Duffy Blood-Group System | 1 | 2011 | 7 | 0.030 |
Why?
|
Minichromosome Maintenance Complex Component 7 | 1 | 2011 | 1 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2014 | 296 | 0.030 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2011 | 39 | 0.030 |
Why?
|
Thiolester Hydrolases | 1 | 2011 | 14 | 0.030 |
Why?
|
Thermodynamics | 1 | 2012 | 309 | 0.030 |
Why?
|
Acylation | 1 | 2011 | 38 | 0.030 |
Why?
|
Myotonin-Protein Kinase | 1 | 2011 | 1 | 0.030 |
Why?
|
Colectomy | 1 | 2012 | 167 | 0.030 |
Why?
|
Histone Acetyltransferases | 1 | 2011 | 38 | 0.030 |
Why?
|
Membrane Potentials | 2 | 2003 | 435 | 0.030 |
Why?
|
Carrier State | 1 | 2011 | 39 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2011 | 154 | 0.020 |
Why?
|
2',5'-Oligoadenylate Synthetase | 1 | 2011 | 9 | 0.020 |
Why?
|
Myxovirus Resistance Proteins | 1 | 2011 | 7 | 0.020 |
Why?
|
Propane | 1 | 2011 | 3 | 0.020 |
Why?
|
Random Allocation | 1 | 2011 | 332 | 0.020 |
Why?
|
Forced Expiratory Volume | 1 | 2011 | 122 | 0.020 |
Why?
|
Airway Obstruction | 1 | 2012 | 109 | 0.020 |
Why?
|
Creatinine | 1 | 2012 | 338 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 2012 | 167 | 0.020 |
Why?
|
Genes, MHC Class I | 1 | 2011 | 48 | 0.020 |
Why?
|
Podocytes | 1 | 2011 | 30 | 0.020 |
Why?
|
Ubiquitins | 1 | 2011 | 38 | 0.020 |
Why?
|
Validation Studies as Topic | 1 | 2010 | 16 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2016 | 797 | 0.020 |
Why?
|
Netherlands | 1 | 2010 | 19 | 0.020 |
Why?
|
Consanguinity | 1 | 2011 | 73 | 0.020 |
Why?
|
Molecular Sequence Annotation | 1 | 2011 | 67 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2012 | 218 | 0.020 |
Why?
|
Methionine Sulfoxide Reductases | 1 | 2010 | 1 | 0.020 |
Why?
|
Treatment Failure | 1 | 2011 | 285 | 0.020 |
Why?
|
Nicotine | 1 | 2012 | 194 | 0.020 |
Why?
|
Receptors, Leptin | 1 | 2010 | 32 | 0.020 |
Why?
|
Waist Circumference | 1 | 2010 | 20 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 2 | 2006 | 245 | 0.020 |
Why?
|
Salmeterol Xinafoate | 1 | 2010 | 16 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2012 | 384 | 0.020 |
Why?
|
Workflow | 1 | 2011 | 77 | 0.020 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2010 | 57 | 0.020 |
Why?
|
Drug Resistance, Viral | 1 | 2010 | 51 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 329 | 0.020 |
Why?
|
Desoxycorticosterone | 1 | 2010 | 18 | 0.020 |
Why?
|
Fluorescence | 1 | 2010 | 102 | 0.020 |
Why?
|
Intellectual Property | 1 | 2010 | 3 | 0.020 |
Why?
|
Mathematical Computing | 1 | 2010 | 21 | 0.020 |
Why?
|
Albuterol | 1 | 2010 | 35 | 0.020 |
Why?
|
Monomeric Clathrin Assembly Proteins | 1 | 2010 | 1 | 0.020 |
Why?
|
alpha-Globins | 1 | 2010 | 1 | 0.020 |
Why?
|
beta-Globins | 1 | 2010 | 2 | 0.020 |
Why?
|
NFATC Transcription Factors | 1 | 2010 | 29 | 0.020 |
Why?
|
Zebrafish Proteins | 1 | 2011 | 144 | 0.020 |
Why?
|
Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2010 | 15 | 0.020 |
Why?
|
LIM-Homeodomain Proteins | 1 | 2010 | 21 | 0.020 |
Why?
|
Hematologic Tests | 1 | 2010 | 14 | 0.020 |
Why?
|
Mutation Rate | 1 | 2010 | 48 | 0.020 |
Why?
|
Blood Cell Count | 1 | 2010 | 79 | 0.020 |
Why?
|
Rho Guanine Nucleotide Exchange Factors | 1 | 2009 | 16 | 0.020 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2010 | 34 | 0.020 |
Why?
|
INDEL Mutation | 1 | 2010 | 30 | 0.020 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2010 | 45 | 0.020 |
Why?
|
Perimenopause | 1 | 2009 | 3 | 0.020 |
Why?
|
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 1 | 2009 | 4 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2010 | 42 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 2010 | 119 | 0.020 |
Why?
|
Chloride-Bicarbonate Antiporters | 1 | 2009 | 11 | 0.020 |
Why?
|
Genetic Diseases, Inborn | 1 | 2010 | 101 | 0.020 |
Why?
|
alpha-Synuclein | 1 | 2009 | 13 | 0.020 |
Why?
|
Cedrus | 1 | 2009 | 2 | 0.020 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2009 | 12 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2009 | 40 | 0.020 |
Why?
|
CA-19-9 Antigen | 1 | 2009 | 11 | 0.020 |
Why?
|
Aldehyde Dehydrogenase, Mitochondrial | 1 | 2009 | 1 | 0.020 |
Why?
|
Sample Size | 1 | 2010 | 130 | 0.020 |
Why?
|
Mites | 1 | 2009 | 16 | 0.020 |
Why?
|
Spinal Cord | 1 | 2011 | 249 | 0.020 |
Why?
|
Hematologic Diseases | 1 | 2010 | 79 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2009 | 62 | 0.020 |
Why?
|
NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2009 | 22 | 0.020 |
Why?
|
Follicle Stimulating Hormone | 1 | 2009 | 147 | 0.020 |
Why?
|
Protein Phosphatase 1 | 1 | 2009 | 34 | 0.020 |
Why?
|
Body Composition | 1 | 2010 | 68 | 0.020 |
Why?
|
Luteinizing Hormone | 1 | 2009 | 167 | 0.020 |
Why?
|
Ubiquitin | 1 | 2010 | 93 | 0.020 |
Why?
|
B-Lymphocyte Subsets | 1 | 2009 | 40 | 0.020 |
Why?
|
Centromere Protein A | 1 | 2009 | 1 | 0.020 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2009 | 3 | 0.020 |
Why?
|
vpr Gene Products, Human Immunodeficiency Virus | 1 | 2009 | 1 | 0.020 |
Why?
|
Apolipoprotein C-III | 1 | 2009 | 8 | 0.020 |
Why?
|
Monosaccharide Transport Proteins | 1 | 1989 | 73 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2010 | 315 | 0.020 |
Why?
|
Chickens | 1 | 2009 | 212 | 0.020 |
Why?
|
Chromosome Segregation | 1 | 2009 | 32 | 0.020 |
Why?
|
Denmark | 1 | 2009 | 15 | 0.020 |
Why?
|
Adenine Nucleotide Translocator 2 | 1 | 2008 | 1 | 0.020 |
Why?
|
Pancreatitis | 1 | 2009 | 87 | 0.020 |
Why?
|
Zebrafish | 1 | 2011 | 309 | 0.020 |
Why?
|
Femur Head | 1 | 2008 | 8 | 0.020 |
Why?
|
Androgens | 1 | 2009 | 167 | 0.020 |
Why?
|
Erythrocytes | 1 | 2010 | 255 | 0.020 |
Why?
|
Leukemia | 1 | 2011 | 320 | 0.020 |
Why?
|
Signaling Lymphocytic Activation Molecule Family | 1 | 2008 | 15 | 0.020 |
Why?
|
Dietary Fats | 1 | 2009 | 135 | 0.020 |
Why?
|
Cystatin M | 1 | 2008 | 2 | 0.020 |
Why?
|
Chicago | 1 | 2013 | 1379 | 0.020 |
Why?
|
RNA, Double-Stranded | 1 | 2008 | 22 | 0.020 |
Why?
|
Tail | 1 | 2008 | 31 | 0.020 |
Why?
|
Collagen Type VI | 1 | 2008 | 5 | 0.020 |
Why?
|
Health | 1 | 2008 | 29 | 0.020 |
Why?
|
Transcription Initiation Site | 1 | 2008 | 45 | 0.020 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2009 | 94 | 0.020 |
Why?
|
Cattle | 1 | 2009 | 376 | 0.020 |
Why?
|
Genetics | 1 | 2008 | 24 | 0.020 |
Why?
|
Pseudogenes | 1 | 2008 | 35 | 0.020 |
Why?
|
Allergens | 1 | 2009 | 179 | 0.020 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2008 | 8 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2009 | 292 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2010 | 502 | 0.020 |
Why?
|
Skin | 1 | 2012 | 554 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2009 | 196 | 0.020 |
Why?
|
Homeobox Protein Nkx-2.5 | 1 | 2008 | 12 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2009 | 305 | 0.020 |
Why?
|
Synovial Membrane | 1 | 2008 | 28 | 0.020 |
Why?
|
Radiography | 1 | 2010 | 813 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2008 | 153 | 0.020 |
Why?
|
Zinc Transporter 8 | 1 | 2007 | 2 | 0.020 |
Why?
|
Markov Chains | 1 | 2008 | 125 | 0.020 |
Why?
|
Receptor, IGF Type 2 | 1 | 2007 | 6 | 0.020 |
Why?
|
Cyclin B | 1 | 2007 | 17 | 0.020 |
Why?
|
Hemorrhage | 1 | 2010 | 268 | 0.020 |
Why?
|
Edar Receptor | 1 | 2007 | 2 | 0.020 |
Why?
|
Dihydrotestosterone | 1 | 2007 | 27 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2010 | 231 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2009 | 178 | 0.020 |
Why?
|
Diet, Atherogenic | 1 | 2007 | 15 | 0.020 |
Why?
|
Overweight | 1 | 2009 | 118 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2008 | 185 | 0.020 |
Why?
|
Host-Parasite Interactions | 1 | 2007 | 30 | 0.020 |
Why?
|
DNA, Ribosomal | 1 | 2007 | 44 | 0.020 |
Why?
|
MAP Kinase Kinase 6 | 1 | 2007 | 12 | 0.020 |
Why?
|
Colonic Polyps | 1 | 2008 | 126 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2009 | 242 | 0.020 |
Why?
|
snRNP Core Proteins | 1 | 2007 | 9 | 0.020 |
Why?
|
Macaca fascicularis | 1 | 2007 | 108 | 0.020 |
Why?
|
Lipids | 1 | 2009 | 269 | 0.020 |
Why?
|
Swine | 1 | 2009 | 555 | 0.020 |
Why?
|
Autophagy-Related Proteins | 1 | 2007 | 21 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2009 | 456 | 0.020 |
Why?
|
Ribonucleoproteins, Small Nuclear | 1 | 2007 | 20 | 0.020 |
Why?
|
Growth Differentiation Factor 5 | 1 | 2007 | 1 | 0.020 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 1 | 2007 | 52 | 0.020 |
Why?
|
Protein Denaturation | 1 | 2007 | 106 | 0.020 |
Why?
|
Body Weight | 1 | 2009 | 459 | 0.020 |
Why?
|
Apelin | 1 | 2007 | 1 | 0.020 |
Why?
|
Apelin Receptors | 1 | 2007 | 1 | 0.020 |
Why?
|
Viral Proteins | 1 | 2009 | 300 | 0.020 |
Why?
|
Heterozygote | 1 | 2008 | 365 | 0.020 |
Why?
|
Mitochondria, Muscle | 1 | 2007 | 26 | 0.020 |
Why?
|
Appetite Regulation | 1 | 2007 | 9 | 0.020 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2006 | 6 | 0.020 |
Why?
|
Suppressor of Cytokine Signaling 1 Protein | 1 | 2006 | 7 | 0.020 |
Why?
|
Guanosine Diphosphate | 1 | 2006 | 19 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2008 | 268 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2007 | 125 | 0.020 |
Why?
|
Angiotensinogen | 1 | 2006 | 8 | 0.020 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2006 | 32 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2011 | 599 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2009 | 295 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2007 | 297 | 0.020 |
Why?
|
Geography | 1 | 2007 | 223 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 2008 | 158 | 0.020 |
Why?
|
Chemokine CCL17 | 1 | 2006 | 2 | 0.020 |
Why?
|
Models, Animal | 1 | 2008 | 263 | 0.020 |
Why?
|
Models, Chemical | 1 | 2007 | 178 | 0.020 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2006 | 135 | 0.020 |
Why?
|
HL-60 Cells | 1 | 2006 | 20 | 0.020 |
Why?
|
Phenylalanine | 1 | 2006 | 37 | 0.020 |
Why?
|
Cranial Irradiation | 1 | 2006 | 36 | 0.020 |
Why?
|
Diamond | 1 | 2006 | 3 | 0.020 |
Why?
|
Spectrometry, X-Ray Emission | 1 | 2006 | 10 | 0.020 |
Why?
|
Fluorine | 1 | 2006 | 17 | 0.020 |
Why?
|
Adsorption | 1 | 2006 | 54 | 0.020 |
Why?
|
LIM Domain Proteins | 1 | 2006 | 25 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2010 | 584 | 0.020 |
Why?
|
Stathmin | 1 | 2006 | 3 | 0.020 |
Why?
|
Gene Components | 1 | 2005 | 6 | 0.020 |
Why?
|
Escherichia coli | 1 | 2009 | 597 | 0.020 |
Why?
|
X-Rays | 1 | 2006 | 130 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 3362 | 0.020 |
Why?
|
Etoposide | 1 | 2006 | 196 | 0.020 |
Why?
|
Nephrectomy | 1 | 2008 | 294 | 0.020 |
Why?
|
Physicians | 1 | 2013 | 673 | 0.020 |
Why?
|
Isoleucine | 1 | 2005 | 17 | 0.020 |
Why?
|
Cyclic AMP | 1 | 2006 | 273 | 0.020 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2005 | 40 | 0.020 |
Why?
|
Respiratory Mucosa | 1 | 2006 | 88 | 0.020 |
Why?
|
Endocytosis | 1 | 2006 | 177 | 0.020 |
Why?
|
Crystallization | 1 | 2006 | 206 | 0.020 |
Why?
|
Rats, Inbred OLETF | 1 | 2005 | 2 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2007 | 407 | 0.020 |
Why?
|
Rats, Inbred BN | 1 | 2005 | 37 | 0.020 |
Why?
|
RNA, Long Noncoding | 1 | 2006 | 102 | 0.020 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2005 | 36 | 0.020 |
Why?
|
Protein Folding | 1 | 2007 | 282 | 0.020 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2005 | 16 | 0.020 |
Why?
|
Matrix Metalloproteinases | 1 | 2005 | 28 | 0.020 |
Why?
|
Carcinogenicity Tests | 1 | 2005 | 5 | 0.020 |
Why?
|
Cilia | 1 | 2005 | 29 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 74 | 0.020 |
Why?
|
Osteopontin | 1 | 2005 | 47 | 0.020 |
Why?
|
CD30 Ligand | 1 | 2004 | 2 | 0.020 |
Why?
|
Carcinoma, Embryonal | 1 | 2004 | 2 | 0.020 |
Why?
|
Clusterin | 1 | 2004 | 13 | 0.020 |
Why?
|
Dinucleotide Repeats | 1 | 2004 | 13 | 0.020 |
Why?
|
Caspase 8 | 1 | 2004 | 34 | 0.020 |
Why?
|
Ki-1 Antigen | 1 | 2004 | 17 | 0.020 |
Why?
|
Aspartic Acid | 1 | 2005 | 64 | 0.020 |
Why?
|
Light | 1 | 2006 | 289 | 0.020 |
Why?
|
Aggrecans | 1 | 2005 | 42 | 0.020 |
Why?
|
Fas Ligand Protein | 1 | 2004 | 49 | 0.020 |
Why?
|
Family | 1 | 2006 | 311 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2004 | 43 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2005 | 165 | 0.020 |
Why?
|
Retroviridae | 1 | 2005 | 79 | 0.020 |
Why?
|
Databases, Factual | 2 | 2002 | 814 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2005 | 87 | 0.020 |
Why?
|
Insulin-Secreting Cells | 1 | 2008 | 397 | 0.020 |
Why?
|
fas Receptor | 1 | 2004 | 75 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2005 | 370 | 0.020 |
Why?
|
Blotting, Southern | 1 | 2004 | 129 | 0.020 |
Why?
|
1-Pyrroline-5-Carboxylate Dehydrogenase | 1 | 2004 | 2 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2004 | 62 | 0.020 |
Why?
|
Two-Hybrid System Techniques | 1 | 2004 | 55 | 0.020 |
Why?
|
Ribosomal Proteins | 1 | 2004 | 43 | 0.020 |
Why?
|
Aldo-Keto Reductases | 1 | 2003 | 1 | 0.020 |
Why?
|
Cathepsin H | 1 | 2003 | 4 | 0.020 |
Why?
|
Aldehyde Reductase | 1 | 2003 | 9 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2005 | 229 | 0.020 |
Why?
|
Th2 Cells | 1 | 2005 | 146 | 0.020 |
Why?
|
Solute Carrier Family 22 Member 5 | 1 | 2003 | 5 | 0.020 |
Why?
|
Solute Carrier Family 12, Member 3 | 1 | 2003 | 7 | 0.020 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2003 | 12 | 0.020 |
Why?
|
BRCA2 Protein | 1 | 2005 | 158 | 0.020 |
Why?
|
Alcian Blue | 1 | 2003 | 3 | 0.010 |
Why?
|
Anthraquinones | 1 | 2003 | 8 | 0.010 |
Why?
|
Sodium Chloride Symporters | 1 | 2003 | 13 | 0.010 |
Why?
|
Annexin A5 | 1 | 2003 | 20 | 0.010 |
Why?
|
Pyrroles | 1 | 2005 | 184 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2006 | 435 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2003 | 173 | 0.010 |
Why?
|
Microtubules | 1 | 2004 | 119 | 0.010 |
Why?
|
Prothrombin | 1 | 2003 | 18 | 0.010 |
Why?
|
Coloring Agents | 1 | 2003 | 64 | 0.010 |
Why?
|
Ocular Physiological Phenomena | 1 | 2003 | 11 | 0.010 |
Why?
|
Spleen | 1 | 2004 | 430 | 0.010 |
Why?
|
Transferases | 1 | 2003 | 24 | 0.010 |
Why?
|
F-Box-WD Repeat-Containing Protein 7 | 1 | 2003 | 4 | 0.010 |
Why?
|
Dystroglycans | 1 | 2003 | 15 | 0.010 |
Why?
|
DNA, Viral | 1 | 2004 | 265 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 2004 | 162 | 0.010 |
Why?
|
Netrin-1 | 1 | 2003 | 2 | 0.010 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2003 | 2 | 0.010 |
Why?
|
Species Specificity | 1 | 2005 | 678 | 0.010 |
Why?
|
Chromosomes | 1 | 2003 | 96 | 0.010 |
Why?
|
DNA, Antisense | 1 | 2003 | 15 | 0.010 |
Why?
|
Adipocytes | 1 | 2004 | 155 | 0.010 |
Why?
|
alpha-Fetoproteins | 1 | 2003 | 45 | 0.010 |
Why?
|
Tunica Media | 1 | 2003 | 16 | 0.010 |
Why?
|
Electroretinography | 1 | 2003 | 76 | 0.010 |
Why?
|
Multiple Organ Failure | 1 | 2003 | 53 | 0.010 |
Why?
|
TNF Receptor-Associated Factor 1 | 1 | 2002 | 4 | 0.010 |
Why?
|
3-Phosphoinositide-Dependent Protein Kinases | 1 | 2002 | 5 | 0.010 |
Why?
|
Forkhead Box Protein O1 | 1 | 2002 | 23 | 0.010 |
Why?
|
Placenta | 1 | 2004 | 175 | 0.010 |
Why?
|
Inhibitor of Differentiation Protein 2 | 1 | 2002 | 15 | 0.010 |
Why?
|
Pancreas | 1 | 2004 | 239 | 0.010 |
Why?
|
Matrix Metalloproteinases, Membrane-Associated | 1 | 2002 | 4 | 0.010 |
Why?
|
Behavior | 1 | 2003 | 85 | 0.010 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2002 | 56 | 0.010 |
Why?
|
Protein Precursors | 1 | 2003 | 143 | 0.010 |
Why?
|
Gene Targeting | 1 | 2003 | 72 | 0.010 |
Why?
|
Fibrosarcoma | 1 | 2003 | 84 | 0.010 |
Why?
|
Carboxylesterase | 1 | 2002 | 10 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 2002 | 39 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2007 | 350 | 0.010 |
Why?
|
Human Genome Project | 1 | 2002 | 19 | 0.010 |
Why?
|
Culture Techniques | 1 | 2002 | 91 | 0.010 |
Why?
|
Intracellular Membranes | 1 | 2002 | 117 | 0.010 |
Why?
|
Jagged-2 Protein | 1 | 2001 | 6 | 0.010 |
Why?
|
Jagged-1 Protein | 1 | 2001 | 11 | 0.010 |
Why?
|
Serrate-Jagged Proteins | 1 | 2001 | 12 | 0.010 |
Why?
|
Heart Conduction System | 1 | 2002 | 108 | 0.010 |
Why?
|
Interferon Regulatory Factors | 1 | 2002 | 67 | 0.010 |
Why?
|
Aorta | 1 | 2003 | 280 | 0.010 |
Why?
|
Coronary Vessels | 1 | 2002 | 177 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2004 | 480 | 0.010 |
Why?
|
Receptors, Notch | 1 | 2001 | 120 | 0.010 |
Why?
|
Osteogenesis | 1 | 2002 | 242 | 0.010 |
Why?
|
Pregnancy | 1 | 2007 | 2894 | 0.010 |
Why?
|
Myocardium | 1 | 2002 | 529 | 0.010 |
Why?
|
Cosmids | 1 | 1993 | 22 | 0.010 |
Why?
|
DNA Probes | 1 | 1993 | 77 | 0.010 |
Why?
|